data_2m1d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m1d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m . . . . . 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.295 0.569 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 tt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m . . . . . 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.01 0.433 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tp -58.7 -37.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -77.69 155.43 31.31 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.578 2.351 . . . . 0.0 113.021 177.558 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.783 -0.081 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.96 156.22 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.147 0.979 . . . . 0.0 113.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -130.8 81.39 1.99 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.244 1.818 . . . . 0.0 107.407 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -155.54 160.35 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.287 1.435 . . . . 0.0 111.056 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -69.86 141.93 53.13 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -140.66 162.12 36.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.8 108.98 5.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.347 2.259 . . . . 0.0 107.537 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -50.08 -25.25 3.27 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.787 2.435 . . . . 0.0 117.206 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.0 p -132.58 -9.59 3.2 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.3 tttt 37.71 56.04 4.18 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 127.41 2.284 . . . . 0.0 115.412 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -63.55 151.18 86.22 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.457 2.771 . . . . 0.0 112.636 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.039 1.736 . . . . 0.0 113.583 179.129 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 CA-C-O 120.984 0.213 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.57 -24.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.647 1.179 . . . . 0.0 113.988 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m -73.54 159.95 32.39 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.83 2.052 . . . . 0.0 112.41 174.337 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.335 0.112 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.34 155.32 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.004 1.322 . . . . 0.0 112.044 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.99 70.83 0.83 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.244 1.818 . . . . 0.0 110.556 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -143.61 177.57 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.998 2.119 . . . . 0.0 110.093 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -70.13 141.37 52.69 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.749 -0.595 . . . . 0.0 110.717 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.19 168.44 24.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -116.66 123.82 48.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.509 1.523 . . . . 0.0 109.996 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -91.01 119.06 30.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.311 1.053 . . . . 0.0 110.727 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.18 134.38 55.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.272 1.829 . . . . 0.0 110.512 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.8 pttp -151.43 169.85 8.74 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 126.155 1.782 . . . . 0.0 111.903 -172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.05 -25.54 44.0 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.026 2.484 . . . . 0.0 115.52 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.822 1.649 . . . . 0.0 114.341 -172.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.97 -35.4 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 0.0 113.221 -170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -73.67 162.7 28.9 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.102 1.361 . . . . 0.0 112.542 173.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.227 0.061 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.72 161.38 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.49 1.516 . . . . 0.0 111.875 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -115.74 98.83 6.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.161 1.385 . . . . 0.0 109.006 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -154.36 167.02 31.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.931 1.693 . . . . 0.0 109.915 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.17 129.49 38.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.24 168.43 23.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -129.0 116.4 19.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.188 1.795 . . . . 0.0 110.046 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -84.58 31.41 0.53 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.104 1.361 . . . . 0.0 114.473 -171.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.281 82.2 p 52.0 39.02 25.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.384 1.873 . . . . 0.0 115.719 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.83 155.23 93.84 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.782 1.233 . . . . 0.0 112.123 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.69 -18.08 13.74 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.801 2.334 . . . . 0.0 114.427 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.134 1.374 . . . . 0.0 113.891 -177.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.54 -22.65 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -128.6 155.45 44.92 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 113.29 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.239 0.066 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.64 169.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.065 1.346 . . . . 0.0 113.783 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.62 73.14 1.11 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.789 2.036 . . . . 0.0 107.898 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -143.23 166.29 25.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.57 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -72.88 141.52 47.92 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -136.7 161.63 35.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -146.22 133.73 20.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -89.43 113.6 24.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.532 1.158 . . . . 0.0 111.605 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -83.03 54.78 2.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 112.605 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.53 151.92 96.95 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.211 1.404 . . . . 0.0 112.352 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.03 155.04 41.21 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.739 2.96 . . . . 0.0 114.128 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.197 1.799 . . . . 0.0 112.805 -178.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.296 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.5 tt -59.5 -22.65 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.84 155.19 39.05 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.955 1.302 . . . . 0.0 113.075 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.13 168.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 112.395 -174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -122.28 89.8 3.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.274 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -152.63 163.22 40.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.356 1.062 . . . . 0.0 111.889 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.72 139.09 55.36 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 167.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.13 168.46 19.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -137.4 134.17 35.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.983 1.713 . . . . 0.0 110.242 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -89.56 1.19 56.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.566 1.946 . . . . 0.0 115.72 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 28.5 p 53.71 28.79 8.54 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.14 103.43 36.17 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.245 1.818 . . . . 0.0 109.368 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.4 150.83 47.19 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.014 2.476 . . . . 0.0 112.41 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.633 1.573 . . . . 0.0 111.167 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 tp -57.1 -37.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 117.945 0.873 . . . . 0.0 112.975 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' H ' ' HB3' ' B' ' 1' ' ' PHE . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -68.21 156.98 36.47 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.945 1.298 . . . . 0.0 113.227 -177.175 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.426 ' HB3' ' H ' ' A' ' 13' ' ' LEU . 88.5 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.277 26.3 m 51.69 -46.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 130.624 3.57 . . . . 0.0 118.821 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 49.47 45.28 24.04 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.954 1.702 . . . . 0.0 112.669 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -144.79 159.77 42.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.835 1.654 . . . . 0.0 110.81 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -73.95 148.6 42.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -138.03 162.54 33.86 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -141.62 -32.63 0.53 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.097 0.959 . . . . 0.0 113.226 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.33 24.2 p90 54.84 134.24 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 129.475 3.11 . . . . 0.0 115.65 -170.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 53.6 p 48.94 38.23 11.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.315 1.846 . . . . 0.0 114.122 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -63.01 134.81 95.94 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.383 1.873 . . . . 0.0 112.027 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 153.02 70.46 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.956 2.437 . . . . 0.0 112.637 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.125 1.77 . . . . 0.0 112.984 178.172 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.48 -22.6 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m -76.11 156.11 34.12 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 113.644 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.39 159.02 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.182 0.993 . . . . 0.0 113.629 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.55 61.93 1.57 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.091 2.157 . . . . 0.0 110.038 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 173.31 11.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.566 1.946 . . . . 0.0 111.038 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -71.75 142.44 49.75 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.657 -0.652 . . . . 0.0 109.621 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -139.91 -54.77 0.54 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 48.63 30.09 2.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.767 1.627 . . . . 0.0 114.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 p90 44.62 35.75 1.51 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.696 2.399 . . . . 0.0 115.052 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.279 57.7 p 51.11 31.6 6.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.735 2.014 . . . . 0.0 115.368 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -51.87 122.34 21.9 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.738 2.015 . . . . 0.0 112.145 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -70.18 144.54 52.08 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.295 2.664 . . . . 0.0 113.415 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.627 1.571 . . . . 0.0 110.81 176.711 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.99 -20.9 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.82 154.94 35.84 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.481 1.912 . . . . 0.0 112.444 173.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.703 0.763 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.11 -38.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.686 1.594 . . . . 0.0 110.946 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -130.34 -176.04 3.83 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.706 2.002 . . . . 0.0 110.702 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 65.45 157.84 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.812 2.445 . . . . 0.0 115.563 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -77.28 144.9 37.81 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -152.47 170.22 20.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -137.38 130.9 31.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.874 . . . . 0.0 109.64 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -86.16 2.86 45.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.296 43.1 p 58.44 39.75 24.82 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.121 1.768 . . . . 0.0 115.736 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -68.84 145.69 96.96 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.657 1.183 . . . . 0.0 110.814 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.17 -23.44 66.65 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.742 2.294 . . . . 0.0 115.44 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.14 1.776 . . . . 0.0 113.076 -176.763 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.94 -21.97 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -84.15 146.34 27.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.251 1.182 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.091 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.648 0.261 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.06 149.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.716 1.206 . . . . 0.0 113.339 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.75 38.35 0.68 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.727 1.611 . . . . 0.0 111.788 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -142.61 173.05 11.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.257 1.823 . . . . 0.0 111.288 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -70.95 140.8 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 169.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -112.6 164.57 13.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -119.8 -17.46 8.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.808 1.643 . . . . 0.0 113.453 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.266 36.4 p90 49.58 19.72 0.42 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.229 2.211 . . . . 0.0 116.165 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.339 6.2 t 43.78 48.4 6.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.557 1.943 . . . . 0.0 112.975 -169.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 147.83 39.67 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.206 1.803 . . . . 0.0 114.004 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.42 152.2 30.0 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.246 2.63 . . . . 0.0 111.856 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.698 1.599 . . . . 0.0 110.87 175.221 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 tp -58.93 -37.09 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.897 0.879 . . . . 0.0 112.488 -173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.45 143.13 53.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.199 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 119.546 -0.264 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.92 -50.5 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER 42.37 41.69 2.32 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.878 2.071 . . . . 0.0 115.439 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -151.48 163.07 39.82 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.072 1.749 . . . . 0.0 110.701 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.99 141.33 56.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -138.5 163.7 31.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -139.34 128.78 24.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.882 1.673 . . . . 0.0 110.257 169.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -81.1 16.76 1.42 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.004 1.722 . . . . 0.0 114.47 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.288 1.8 t 57.87 -14.32 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.992 3.317 . . . . 0.0 118.509 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -78.76 146.96 69.98 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.656 1.183 . . . . 0.0 111.707 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.99 160.13 50.32 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.256 2.638 . . . . 0.0 113.089 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.91 1.684 . . . . 0.0 112.591 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.06 -40.29 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.603 1.161 . . . . 0.0 112.947 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -74.48 171.17 14.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.975 2.11 . . . . 0.0 114.833 -173.316 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.8 t80 . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.4 153.69 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.35 -0.844 . . . . 0.0 112.658 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -130.48 91.55 3.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.189 1.395 . . . . 0.0 108.656 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.92 166.16 34.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.234 1.414 . . . . 0.0 110.817 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.67 139.71 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -72.68 169.65 16.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -111.77 153.52 26.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.483 1.913 . . . . 0.0 109.818 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -137.05 134.59 36.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.286 1.041 . . . . 0.0 112.141 170.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.4 p -77.03 155.18 32.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.649 1.58 . . . . 0.0 112.332 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -64.55 133.54 95.73 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.506 1.122 . . . . 0.0 111.3 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.97 -26.38 43.74 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.939 2.426 . . . . 0.0 115.167 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.009 1.724 . . . . 0.0 113.364 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -61.06 -43.07 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.163 0.985 . . . . 0.0 113.172 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m -67.31 157.35 34.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.27 1.428 . . . . 0.0 113.152 -176.621 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.167 0.032 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.23 160.01 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 125.409 1.483 . . . . 0.0 112.608 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -122.0 87.74 2.81 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.513 1.525 . . . . 0.0 109.52 174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.01 173.93 11.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.842 2.057 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -72.28 135.99 46.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -135.51 164.08 28.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.11 -35.82 0.55 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.043 1.737 . . . . 0.0 112.988 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.351 41.6 p90 47.8 -81.63 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.235 2.214 . . . . 0.0 114.635 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -136.94 0.66 2.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.59 1.556 . . . . 0.0 114.385 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -145.61 129.94 8.8 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.555 1.142 . . . . 0.0 112.737 -169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.34 -25.19 7.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.808 2.338 . . . . 0.0 113.407 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.517 1.927 . . . . 0.0 112.429 -177.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt -76.02 -23.03 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.75 160.19 31.04 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.1 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.55 1.94 . . . . 0.0 112.448 174.789 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.7 160.89 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.24 1.016 . . . . 0.0 113.189 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -112.68 31.55 6.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.247 1.819 . . . . 0.0 110.855 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.75 159.2 39.14 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.437 1.895 . . . . 0.0 111.939 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -73.34 149.12 42.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.318 0.647 . . . . 0.0 109.845 169.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.83 168.27 24.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -138.2 99.89 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.11 1.764 . . . . 0.0 109.137 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -7.0 53.33 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.315 7.6 t 56.17 -46.19 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 130.61 3.564 . . . . 0.0 117.803 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt 61.82 152.79 0.11 Allowed Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 130.015 3.326 . . . . 0.0 115.495 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.21 -19.17 20.21 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.954 2.436 . . . . 0.0 113.411 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.666 1.987 . . . . 0.0 112.222 -176.529 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -69.07 -35.75 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.637 -0.92 . . . . 0.0 113.244 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.63 149.51 49.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.337 1.055 . . . . 0.0 113.711 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.66 161.91 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.405 1.082 . . . . 0.0 113.804 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 58.77 1.63 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.33 1.852 . . . . 0.0 110.144 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -136.7 162.34 33.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.694 1.597 . . . . 0.0 111.885 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -71.46 145.05 49.48 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 167.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -124.23 166.22 16.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -117.48 138.16 52.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.055 1.742 . . . . 0.0 110.43 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -99.02 22.12 10.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.246 1.419 . . . . 0.0 113.55 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 49.5 p 53.03 -114.92 0.9 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.26 1.824 . . . . 0.0 113.847 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.16 88.51 21.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.375 1.87 . . . . 0.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -71.44 -28.3 18.08 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.674 2.249 . . . . 0.0 116.336 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.251 1.141 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 121.237 0.354 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.57 -23.23 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -169.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m -78.29 159.48 28.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 124.882 1.273 . . . . 0.0 113.068 177.064 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -70.33 135.2 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.175 -0.953 . . . . 0.0 111.952 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -124.97 82.64 2.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.063 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -144.5 174.67 10.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.585 2.354 . . . . 0.0 109.406 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.91 141.37 51.16 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.606 169.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -150.67 -43.21 0.12 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.55 35.05 1.85 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.552 2.341 . . . . 0.0 115.476 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 30.9 p90 44.57 35.28 1.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.4 2.28 . . . . 0.0 115.961 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 44.1 p 58.92 24.87 13.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -56.95 130.46 79.16 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.019 1.328 . . . . 0.0 110.82 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.46 -20.96 4.57 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.959 2.439 . . . . 0.0 114.485 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.508 1.523 . . . . 0.0 114.24 -174.569 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.466 0 CA-C-O 120.853 0.14 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -95.94 -23.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -71.52 162.41 29.48 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.647 1.979 . . . . 0.0 112.334 176.174 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.16 150.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.296 1.039 . . . . 0.0 112.863 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.12 68.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.295 1.438 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -139.21 172.8 12.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.066 1.747 . . . . 0.0 111.473 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -68.95 144.18 54.22 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 169.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.52 163.33 33.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -140.73 -26.32 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.35 52.9 p90 46.83 -97.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.048 1.739 . . . . 0.0 113.828 -169.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 158.29 43.81 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.412 1.885 . . . . 0.0 111.321 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.19 150.99 94.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 112.289 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.7 152.95 59.26 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.55 2.833 . . . . 0.0 113.735 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.761 1.624 . . . . 0.0 113.04 176.619 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.7 tp -56.14 -40.1 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.703 1.601 . . . . 0.0 113.235 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m -72.53 158.78 35.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.561 1.944 . . . . 0.0 112.333 175.002 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.33 -24.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 53.83 51.4 14.95 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.577 1.551 . . . . 0.0 112.386 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -149.91 162.48 40.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.549 1.94 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -69.46 147.91 50.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -147.01 168.23 22.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -125.11 164.65 19.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 110.305 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -142.87 134.2 26.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.949 0.88 . . . . 0.0 112.346 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 144.61 44.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.186 1.794 . . . . 0.0 110.37 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.33 138.79 11.39 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.539 1.536 . . . . 0.0 110.052 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.56 117.11 4.2 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.3 2.0 . . . . 0.0 110.206 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.754 1.621 . . . . 0.0 111.479 -170.519 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.452 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -72.76 -24.7 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m -118.69 164.02 15.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.658 1.983 . . . . 0.0 114.936 -169.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.69 156.75 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.335 1.054 . . . . 0.0 113.161 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -127.38 72.99 1.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.67 1.988 . . . . 0.0 106.978 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.35 175.21 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.604 1.961 . . . . 0.0 111.313 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -76.7 142.12 40.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.242 0.617 . . . . 0.0 109.833 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -136.15 -52.7 0.73 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 50.14 28.07 2.87 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.317 1.847 . . . . 0.0 115.013 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 43.72 32.14 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.832 2.453 . . . . 0.0 116.379 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p 58.61 7.74 0.78 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? 32.86 60.63 1.51 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 128.427 2.691 . . . . 0.0 115.99 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.55 120.89 8.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.516 2.144 . . . . 0.0 110.847 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.175 1.79 . . . . 0.0 112.415 -174.533 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 CA-C-O 120.441 -0.089 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.1 tp -55.13 -40.2 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.366 1.466 . . . . 0.0 112.705 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m -70.04 151.41 45.56 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.506 1.523 . . . . 0.0 112.651 -171.774 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.326 26.7 m 45.91 45.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.483 1.913 . . . . 0.0 114.852 -172.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 64.53 55.22 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.658 1.983 . . . . 0.0 114.172 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.27 160.26 40.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.828 1.651 . . . . 0.0 112.694 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -78.74 144.84 34.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.808 0.843 . . . . 0.0 109.037 167.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.15 170.99 16.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -111.69 147.52 35.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.607 1.563 . . . . 0.0 110.523 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -128.4 120.72 27.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 111.233 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -83.94 60.17 5.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.034 1.334 . . . . 0.0 112.456 -171.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 77.9 tttt 51.16 69.09 2.76 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 127.452 2.301 . . . . 0.0 114.644 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 -21.66 41.13 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.035 2.49 . . . . 0.0 113.557 172.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.544 1.938 . . . . 0.0 111.193 177.344 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.85 -22.2 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m -73.88 157.85 35.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.842 2.057 . . . . 0.0 112.62 174.785 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 119.969 -0.063 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.7 m -137.0 146.29 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.309 1.444 . . . . 0.0 111.399 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -92.31 133.28 35.99 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.335 1.054 . . . . 0.0 110.38 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -162.49 166.34 25.0 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.971 1.308 . . . . 0.0 111.169 -169.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -77.79 80.22 4.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.83 -78.57 0.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 49.82 71.86 0.36 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.56 1.544 . . . . 0.0 111.484 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.16 -41.68 68.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -168.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -146.89 167.35 24.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.552 1.541 . . . . 0.0 111.302 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -139.59 152.24 68.23 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.137 1.775 . . . . 0.0 111.919 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.01 -22.55 11.33 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.025 2.483 . . . . 0.0 113.381 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.863 1.665 . . . . 0.0 112.243 -176.564 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD13 ' A' ' 2' ' ' ILE . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m . . . . . 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.295 0.569 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 19' ' ' TYR . 10.3 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 2' ' ' ILE . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD12 ' A' ' 2' ' ' ILE . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 19' ' ' TYR . 20.5 tt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 2' ' ' ILE . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m . . . . . 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 2' ' ' ILE . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.4 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.1 tt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.529 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CD2' HD13 ' A' ' 2' ' ' ILE . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.9 tp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CD2' HD13 ' A' ' 2' ' ' ILE . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.408 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.5 tp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 2' ' ' ILE . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.54 HD12 ' CD2' ' A' ' 19' ' ' TYR . 13.1 tt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.54 ' CD2' HD12 ' A' ' 2' ' ' ILE . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 2' ' ' ILE . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.01 0.433 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 19' ' ' TYR . 7.1 tp . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 13' ' ' LEU . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 2' ' ' ILE . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.653 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.2 tt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.653 ' CD2' HD12 ' A' ' 2' ' ' ILE . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp -58.7 -37.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD13 ' A' ' 2' ' ' ILE . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -77.69 155.43 31.31 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.578 2.351 . . . . 0.0 113.021 177.558 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.783 -0.081 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.96 156.22 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.147 0.979 . . . . 0.0 113.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -130.8 81.39 1.99 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.244 1.818 . . . . 0.0 107.407 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -155.54 160.35 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.287 1.435 . . . . 0.0 111.056 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -69.86 141.93 53.13 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -140.66 162.12 36.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.8 108.98 5.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.347 2.259 . . . . 0.0 107.537 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -50.08 -25.25 3.27 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.787 2.435 . . . . 0.0 117.206 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.0 p -132.58 -9.59 3.2 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.3 tttt 37.71 56.04 4.18 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 127.41 2.284 . . . . 0.0 115.412 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -63.55 151.18 86.22 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.457 2.771 . . . . 0.0 112.636 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.039 1.736 . . . . 0.0 113.583 179.129 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 CA-C-O 120.984 0.213 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.57 -24.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.647 1.179 . . . . 0.0 113.988 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m -73.54 159.95 32.39 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.83 2.052 . . . . 0.0 112.41 174.337 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.335 0.112 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.34 155.32 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.004 1.322 . . . . 0.0 112.044 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.99 70.83 0.83 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.244 1.818 . . . . 0.0 110.556 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -143.61 177.57 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.998 2.119 . . . . 0.0 110.093 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -70.13 141.37 52.69 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.749 -0.595 . . . . 0.0 110.717 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.19 168.44 24.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -116.66 123.82 48.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.509 1.523 . . . . 0.0 109.996 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -91.01 119.06 30.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.311 1.053 . . . . 0.0 110.727 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.18 134.38 55.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.272 1.829 . . . . 0.0 110.512 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.8 pttp -151.43 169.85 8.74 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 126.155 1.782 . . . . 0.0 111.903 -172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.05 -25.54 44.0 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.026 2.484 . . . . 0.0 115.52 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.822 1.649 . . . . 0.0 114.341 -172.775 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 19' ' ' TYR . 10.3 tp -60.97 -35.4 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 0.0 113.221 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 2' ' ' ILE . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -73.67 162.7 28.9 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.102 1.361 . . . . 0.0 112.542 173.445 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.227 0.061 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.72 161.38 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.49 1.516 . . . . 0.0 111.875 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -115.74 98.83 6.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.161 1.385 . . . . 0.0 109.006 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -154.36 167.02 31.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.931 1.693 . . . . 0.0 109.915 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.17 129.49 38.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.24 168.43 23.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -129.0 116.4 19.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.188 1.795 . . . . 0.0 110.046 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -84.58 31.41 0.53 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.104 1.361 . . . . 0.0 114.473 -171.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.281 82.2 p 52.0 39.02 25.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.384 1.873 . . . . 0.0 115.719 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.83 155.23 93.84 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.782 1.233 . . . . 0.0 112.123 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.69 -18.08 13.74 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.801 2.334 . . . . 0.0 114.427 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.134 1.374 . . . . 0.0 113.891 -177.403 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt -63.54 -22.65 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -169.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD12 ' A' ' 2' ' ' ILE . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -128.6 155.45 44.92 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 113.29 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.239 0.066 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.64 169.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.065 1.346 . . . . 0.0 113.783 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.62 73.14 1.11 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.789 2.036 . . . . 0.0 107.898 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -143.23 166.29 25.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.57 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -72.88 141.52 47.92 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -136.7 161.63 35.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -146.22 133.73 20.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -89.43 113.6 24.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.532 1.158 . . . . 0.0 111.605 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -83.03 54.78 2.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 112.605 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.53 151.92 96.95 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.211 1.404 . . . . 0.0 112.352 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.03 155.04 41.21 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.739 2.96 . . . . 0.0 114.128 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.197 1.799 . . . . 0.0 112.805 -178.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.296 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 19' ' ' TYR . 20.5 tt -59.5 -22.65 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 2' ' ' ILE . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.84 155.19 39.05 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.955 1.302 . . . . 0.0 113.075 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.13 168.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 112.395 -174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -122.28 89.8 3.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.274 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -152.63 163.22 40.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.356 1.062 . . . . 0.0 111.889 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.72 139.09 55.36 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 167.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.13 168.46 19.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -137.4 134.17 35.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.983 1.713 . . . . 0.0 110.242 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -89.56 1.19 56.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.566 1.946 . . . . 0.0 115.72 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 28.5 p 53.71 28.79 8.54 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.14 103.43 36.17 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.245 1.818 . . . . 0.0 109.368 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.4 150.83 47.19 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.014 2.476 . . . . 0.0 112.41 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.633 1.573 . . . . 0.0 111.167 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp -57.1 -37.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 117.945 0.873 . . . . 0.0 112.975 -170.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' H ' ' HB3' ' B' ' 1' ' ' PHE . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 2' ' ' ILE . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -68.21 156.98 36.47 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.945 1.298 . . . . 0.0 113.227 -177.175 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 13' ' ' LEU . 88.5 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.277 26.3 m 51.69 -46.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 130.624 3.57 . . . . 0.0 118.821 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 49.47 45.28 24.04 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.954 1.702 . . . . 0.0 112.669 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -144.79 159.77 42.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.835 1.654 . . . . 0.0 110.81 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -73.95 148.6 42.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -138.03 162.54 33.86 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -141.62 -32.63 0.53 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.097 0.959 . . . . 0.0 113.226 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.33 24.2 p90 54.84 134.24 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 129.475 3.11 . . . . 0.0 115.65 -170.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 53.6 p 48.94 38.23 11.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.315 1.846 . . . . 0.0 114.122 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -63.01 134.81 95.94 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.383 1.873 . . . . 0.0 112.027 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 153.02 70.46 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.956 2.437 . . . . 0.0 112.637 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.125 1.77 . . . . 0.0 112.984 178.172 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.4 tt -62.48 -22.6 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m -76.11 156.11 34.12 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 113.644 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.39 159.02 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.182 0.993 . . . . 0.0 113.629 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.55 61.93 1.57 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.091 2.157 . . . . 0.0 110.038 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 173.31 11.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.566 1.946 . . . . 0.0 111.038 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -71.75 142.44 49.75 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.657 -0.652 . . . . 0.0 109.621 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -139.91 -54.77 0.54 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 48.63 30.09 2.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.767 1.627 . . . . 0.0 114.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 p90 44.62 35.75 1.51 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.696 2.399 . . . . 0.0 115.052 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.279 57.7 p 51.11 31.6 6.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.735 2.014 . . . . 0.0 115.368 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -51.87 122.34 21.9 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.738 2.015 . . . . 0.0 112.145 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -70.18 144.54 52.08 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.295 2.664 . . . . 0.0 113.415 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.627 1.571 . . . . 0.0 110.81 176.711 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.99 -20.9 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.82 154.94 35.84 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.481 1.912 . . . . 0.0 112.444 173.932 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.703 0.763 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.11 -38.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.686 1.594 . . . . 0.0 110.946 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -130.34 -176.04 3.83 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.706 2.002 . . . . 0.0 110.702 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 65.45 157.84 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.812 2.445 . . . . 0.0 115.563 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -77.28 144.9 37.81 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -152.47 170.22 20.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -137.38 130.9 31.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.874 . . . . 0.0 109.64 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -86.16 2.86 45.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.296 43.1 p 58.44 39.75 24.82 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.121 1.768 . . . . 0.0 115.736 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -68.84 145.69 96.96 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.657 1.183 . . . . 0.0 110.814 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.17 -23.44 66.65 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.742 2.294 . . . . 0.0 115.44 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.14 1.776 . . . . 0.0 113.076 -176.763 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.1 tt -59.94 -21.97 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.529 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -84.15 146.34 27.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.251 1.182 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.091 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.648 0.261 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.06 149.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.716 1.206 . . . . 0.0 113.339 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.75 38.35 0.68 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.727 1.611 . . . . 0.0 111.788 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -142.61 173.05 11.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.257 1.823 . . . . 0.0 111.288 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -70.95 140.8 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 169.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -112.6 164.57 13.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -119.8 -17.46 8.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.808 1.643 . . . . 0.0 113.453 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.266 36.4 p90 49.58 19.72 0.42 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.229 2.211 . . . . 0.0 116.165 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.339 6.2 t 43.78 48.4 6.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.557 1.943 . . . . 0.0 112.975 -169.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 147.83 39.67 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.206 1.803 . . . . 0.0 114.004 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.42 152.2 30.0 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.246 2.63 . . . . 0.0 111.856 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.698 1.599 . . . . 0.0 110.87 175.221 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp -58.93 -37.09 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.897 0.879 . . . . 0.0 112.488 -173.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CD2' HD13 ' A' ' 2' ' ' ILE . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.45 143.13 53.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.199 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 119.546 -0.264 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.92 -50.5 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER 42.37 41.69 2.32 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.878 2.071 . . . . 0.0 115.439 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -151.48 163.07 39.82 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.072 1.749 . . . . 0.0 110.701 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.99 141.33 56.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -138.5 163.7 31.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -139.34 128.78 24.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.882 1.673 . . . . 0.0 110.257 169.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -81.1 16.76 1.42 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.004 1.722 . . . . 0.0 114.47 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.288 1.8 t 57.87 -14.32 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.992 3.317 . . . . 0.0 118.509 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -78.76 146.96 69.98 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.656 1.183 . . . . 0.0 111.707 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.99 160.13 50.32 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.256 2.638 . . . . 0.0 113.089 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.91 1.684 . . . . 0.0 112.591 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.9 tp -58.06 -40.29 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.603 1.161 . . . . 0.0 112.947 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CD2' HD13 ' A' ' 2' ' ' ILE . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -74.48 171.17 14.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.975 2.11 . . . . 0.0 114.833 -173.316 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.8 t80 . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.4 153.69 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.35 -0.844 . . . . 0.0 112.658 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -130.48 91.55 3.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.189 1.395 . . . . 0.0 108.656 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.92 166.16 34.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.234 1.414 . . . . 0.0 110.817 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.67 139.71 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -72.68 169.65 16.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -111.77 153.52 26.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.483 1.913 . . . . 0.0 109.818 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -137.05 134.59 36.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.286 1.041 . . . . 0.0 112.141 170.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.4 p -77.03 155.18 32.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.649 1.58 . . . . 0.0 112.332 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -64.55 133.54 95.73 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.506 1.122 . . . . 0.0 111.3 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.97 -26.38 43.74 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.939 2.426 . . . . 0.0 115.167 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.009 1.724 . . . . 0.0 113.364 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.408 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.5 tp -61.06 -43.07 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.163 0.985 . . . . 0.0 113.172 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 2' ' ' ILE . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m -67.31 157.35 34.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.27 1.428 . . . . 0.0 113.152 -176.621 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.167 0.032 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.23 160.01 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 125.409 1.483 . . . . 0.0 112.608 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -122.0 87.74 2.81 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.513 1.525 . . . . 0.0 109.52 174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.01 173.93 11.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.842 2.057 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -72.28 135.99 46.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -135.51 164.08 28.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.11 -35.82 0.55 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.043 1.737 . . . . 0.0 112.988 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.351 41.6 p90 47.8 -81.63 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.235 2.214 . . . . 0.0 114.635 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -136.94 0.66 2.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.59 1.556 . . . . 0.0 114.385 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -145.61 129.94 8.8 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.555 1.142 . . . . 0.0 112.737 -169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.34 -25.19 7.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.808 2.338 . . . . 0.0 113.407 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.517 1.927 . . . . 0.0 112.429 -177.889 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt -76.02 -23.03 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.75 160.19 31.04 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.1 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.55 1.94 . . . . 0.0 112.448 174.789 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.7 160.89 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.24 1.016 . . . . 0.0 113.189 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -112.68 31.55 6.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.247 1.819 . . . . 0.0 110.855 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.75 159.2 39.14 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.437 1.895 . . . . 0.0 111.939 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -73.34 149.12 42.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.318 0.647 . . . . 0.0 109.845 169.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.83 168.27 24.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -138.2 99.89 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.11 1.764 . . . . 0.0 109.137 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -7.0 53.33 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.315 7.6 t 56.17 -46.19 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 130.61 3.564 . . . . 0.0 117.803 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt 61.82 152.79 0.11 Allowed Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 130.015 3.326 . . . . 0.0 115.495 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.21 -19.17 20.21 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.954 2.436 . . . . 0.0 113.411 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.666 1.987 . . . . 0.0 112.222 -176.529 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -69.07 -35.75 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.637 -0.92 . . . . 0.0 113.244 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.63 149.51 49.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.337 1.055 . . . . 0.0 113.711 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.66 161.91 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.405 1.082 . . . . 0.0 113.804 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 58.77 1.63 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.33 1.852 . . . . 0.0 110.144 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -136.7 162.34 33.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.694 1.597 . . . . 0.0 111.885 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -71.46 145.05 49.48 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 167.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -124.23 166.22 16.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -117.48 138.16 52.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.055 1.742 . . . . 0.0 110.43 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -99.02 22.12 10.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.246 1.419 . . . . 0.0 113.55 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 49.5 p 53.03 -114.92 0.9 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.26 1.824 . . . . 0.0 113.847 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.16 88.51 21.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.375 1.87 . . . . 0.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -71.44 -28.3 18.08 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.674 2.249 . . . . 0.0 116.336 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.251 1.141 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 121.237 0.354 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.54 HD12 ' CD2' ' A' ' 19' ' ' TYR . 13.1 tt -67.57 -23.23 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -169.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.54 ' CD2' HD12 ' A' ' 2' ' ' ILE . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m -78.29 159.48 28.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 124.882 1.273 . . . . 0.0 113.068 177.064 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -70.33 135.2 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.175 -0.953 . . . . 0.0 111.952 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -124.97 82.64 2.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.063 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -144.5 174.67 10.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.585 2.354 . . . . 0.0 109.406 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.91 141.37 51.16 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.606 169.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -150.67 -43.21 0.12 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.55 35.05 1.85 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.552 2.341 . . . . 0.0 115.476 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 30.9 p90 44.57 35.28 1.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.4 2.28 . . . . 0.0 115.961 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 44.1 p 58.92 24.87 13.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -56.95 130.46 79.16 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.019 1.328 . . . . 0.0 110.82 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.46 -20.96 4.57 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.959 2.439 . . . . 0.0 114.485 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.508 1.523 . . . . 0.0 114.24 -174.569 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.466 0 CA-C-O 120.853 0.14 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -95.94 -23.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -71.52 162.41 29.48 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.647 1.979 . . . . 0.0 112.334 176.174 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.16 150.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.296 1.039 . . . . 0.0 112.863 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.12 68.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.295 1.438 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -139.21 172.8 12.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.066 1.747 . . . . 0.0 111.473 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -68.95 144.18 54.22 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 169.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.52 163.33 33.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -140.73 -26.32 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.35 52.9 p90 46.83 -97.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.048 1.739 . . . . 0.0 113.828 -169.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 158.29 43.81 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.412 1.885 . . . . 0.0 111.321 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.19 150.99 94.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 112.289 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.7 152.95 59.26 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.55 2.833 . . . . 0.0 113.735 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.761 1.624 . . . . 0.0 113.04 176.619 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp -56.14 -40.1 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.703 1.601 . . . . 0.0 113.235 -174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 2' ' ' ILE . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m -72.53 158.78 35.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.561 1.944 . . . . 0.0 112.333 175.002 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.33 -24.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 53.83 51.4 14.95 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.577 1.551 . . . . 0.0 112.386 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -149.91 162.48 40.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.549 1.94 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -69.46 147.91 50.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -147.01 168.23 22.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -125.11 164.65 19.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 110.305 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -142.87 134.2 26.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.949 0.88 . . . . 0.0 112.346 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 144.61 44.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.186 1.794 . . . . 0.0 110.37 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.33 138.79 11.39 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.539 1.536 . . . . 0.0 110.052 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.56 117.11 4.2 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.3 2.0 . . . . 0.0 110.206 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.754 1.621 . . . . 0.0 111.479 -170.519 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.452 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -72.76 -24.7 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m -118.69 164.02 15.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.658 1.983 . . . . 0.0 114.936 -169.74 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.69 156.75 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.335 1.054 . . . . 0.0 113.161 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -127.38 72.99 1.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.67 1.988 . . . . 0.0 106.978 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.35 175.21 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.604 1.961 . . . . 0.0 111.313 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -76.7 142.12 40.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.242 0.617 . . . . 0.0 109.833 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -136.15 -52.7 0.73 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 50.14 28.07 2.87 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.317 1.847 . . . . 0.0 115.013 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 43.72 32.14 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.832 2.453 . . . . 0.0 116.379 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p 58.61 7.74 0.78 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? 32.86 60.63 1.51 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 128.427 2.691 . . . . 0.0 115.99 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.55 120.89 8.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.516 2.144 . . . . 0.0 110.847 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.175 1.79 . . . . 0.0 112.415 -174.533 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 CA-C-O 120.441 -0.089 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 19' ' ' TYR . 7.1 tp -55.13 -40.2 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.366 1.466 . . . . 0.0 112.705 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.562 HD12 ' H ' ' A' ' 13' ' ' LEU . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 2' ' ' ILE . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m -70.04 151.41 45.56 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.506 1.523 . . . . 0.0 112.651 -171.774 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.326 26.7 m 45.91 45.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.483 1.913 . . . . 0.0 114.852 -172.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 64.53 55.22 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.658 1.983 . . . . 0.0 114.172 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.27 160.26 40.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.828 1.651 . . . . 0.0 112.694 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -78.74 144.84 34.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.808 0.843 . . . . 0.0 109.037 167.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.15 170.99 16.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -111.69 147.52 35.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.607 1.563 . . . . 0.0 110.523 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -128.4 120.72 27.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 111.233 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -83.94 60.17 5.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.034 1.334 . . . . 0.0 112.456 -171.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 77.9 tttt 51.16 69.09 2.76 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 127.452 2.301 . . . . 0.0 114.644 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 -21.66 41.13 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.035 2.49 . . . . 0.0 113.557 172.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.544 1.938 . . . . 0.0 111.193 177.344 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.653 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.2 tt -62.85 -22.2 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.653 ' CD2' HD12 ' A' ' 2' ' ' ILE . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m -73.88 157.85 35.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.842 2.057 . . . . 0.0 112.62 174.785 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 119.969 -0.063 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.7 m -137.0 146.29 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.309 1.444 . . . . 0.0 111.399 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -92.31 133.28 35.99 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.335 1.054 . . . . 0.0 110.38 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -162.49 166.34 25.0 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.971 1.308 . . . . 0.0 111.169 -169.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -77.79 80.22 4.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.83 -78.57 0.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 49.82 71.86 0.36 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.56 1.544 . . . . 0.0 111.484 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.16 -41.68 68.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -168.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -146.89 167.35 24.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.552 1.541 . . . . 0.0 111.302 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -139.59 152.24 68.23 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.137 1.775 . . . . 0.0 111.919 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.01 -22.55 11.33 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.025 2.483 . . . . 0.0 113.381 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.863 1.665 . . . . 0.0 112.243 -176.564 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD13 ' A' ' 2' ' ' ILE . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m . . . . . 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.295 0.569 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 19' ' ' TYR . 10.3 tp . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 2' ' ' ILE . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD12 ' A' ' 2' ' ' ILE . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 19' ' ' TYR . 20.5 tt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 2' ' ' ILE . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m . . . . . 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 2' ' ' ILE . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.4 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.1 tt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.529 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CD2' HD13 ' A' ' 2' ' ' ILE . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.9 tp . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CD2' HD13 ' A' ' 2' ' ' ILE . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.408 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.5 tp . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 2' ' ' ILE . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.54 HD12 ' CD2' ' A' ' 19' ' ' TYR . 13.1 tt . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.54 ' CD2' HD12 ' A' ' 2' ' ' ILE . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.38 0.61 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 2' ' ' ILE . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.01 0.433 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 19' ' ' TYR . 7.1 tp . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' HD12 ' A' ' 13' ' ' LEU . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 2' ' ' ILE . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.653 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.2 tt . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.653 ' CD2' HD12 ' A' ' 2' ' ' ILE . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp -58.7 -37.83 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -171.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.15 -40.32 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -71.19 -24.75 62.29 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.623 -0.673 . . . . 0.0 112.391 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -87.01 -43.77 12.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.246 1.019 . . . . 0.0 112.802 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.7 m -98.43 -34.51 10.61 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -86.45 -51.4 6.22 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.484 1.038 . . . . 0.0 112.194 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -93.07 -7.55 45.3 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.626 1.171 . . . . 0.0 113.819 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -141.7 -171.69 3.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.458 1.903 . . . . 0.0 110.899 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.8 mt -99.53 137.7 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.327 1.451 . . . . 0.0 110.305 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.3 p -125.66 166.63 16.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.584 1.554 . . . . 0.0 111.78 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -134.25 169.35 17.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.838 1.255 . . . . 0.0 112.811 -175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.2 tp -44.12 -40.01 4.66 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.764 2.026 . . . . 0.0 111.918 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -77.97 -12.74 60.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.014 0.926 . . . . 0.0 113.42 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -97.88 -44.55 6.65 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.543 1.537 . . . . 0.0 110.365 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.06 -39.81 75.65 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 113.575 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -62.21 -19.54 63.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -70.21 -11.97 61.27 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.024 -1.048 . . . . 0.0 113.004 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' CD2' HD13 ' A' ' 2' ' ' ILE . 30.0 m-85 -108.02 2.49 23.2 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.163 1.385 . . . . 0.0 112.92 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.8 m -77.69 155.43 31.31 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.954 -1.091 . . . . 0.0 112.276 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.578 2.351 . . . . 0.0 113.021 177.558 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.783 -0.081 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 m -69.96 156.22 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.147 0.979 . . . . 0.0 113.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -130.8 81.39 1.99 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.244 1.818 . . . . 0.0 107.407 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -155.54 160.35 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.287 1.435 . . . . 0.0 111.056 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -69.86 141.93 53.13 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -139.29 113.52 8.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.693 1.997 . . . . 0.0 108.207 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.67 153.1 51.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.856 0.862 . . . . 0.0 111.703 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.17 -122.96 31.95 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.549 0.595 . . . . 0.0 111.968 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 23.6 m -59.7 -33.05 71.1 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.961 0.904 . . . . 0.0 113.001 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -70.03 -38.7 75.94 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.813 -0.554 . . . . 0.0 111.68 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.86 -48.52 76.4 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.759 1.224 . . . . 0.0 110.6 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.5 m -74.08 -35.16 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.78 -43.32 80.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.798 0.726 . . . . 0.0 111.518 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.7 81.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.71 -44.9 92.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.12 0.568 . . . . 0.0 110.432 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -64.6 -36.37 84.03 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.12 -0.988 . . . . 0.0 113.013 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.9 tp -66.43 -33.91 76.76 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.208 1.003 . . . . 0.0 112.167 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.52 -40.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.021 0.928 . . . . 0.0 111.302 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.1 m -69.83 -21.57 63.37 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.313 -0.867 . . . . 0.0 112.095 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.89 53.06 42.18 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.88 1.229 . . . . 0.0 113.191 171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 68.04 7.14 5.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.504 1.921 . . . . 0.0 116.044 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -67.23 -26.42 66.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.693 -1.254 . . . . 0.0 112.097 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.58 167.19 43.3 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.795 1.664 . . . . 0.0 112.772 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -140.66 162.12 36.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.992 1.317 . . . . 0.0 114.175 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -141.8 108.98 5.5 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.347 2.259 . . . . 0.0 107.537 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -50.08 -25.25 3.27 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.787 2.435 . . . . 0.0 117.206 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.0 p -132.58 -9.59 3.2 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.3 tttt 37.71 56.04 4.18 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 127.41 2.284 . . . . 0.0 115.412 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -63.55 151.18 86.22 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.457 2.771 . . . . 0.0 112.636 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.039 1.736 . . . . 0.0 113.583 179.129 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 CA-C-O 120.984 0.213 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 tt -83.57 -24.84 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.647 1.179 . . . . 0.0 113.988 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.94 -35.69 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.353 -1.467 . . . . 0.0 110.097 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -76.24 -6.9 53.48 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.437 1.495 . . . . 0.0 113.813 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -103.88 -48.49 3.9 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.672 1.589 . . . . 0.0 112.972 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -109.72 -27.83 9.14 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.44 -45.93 7.91 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.543 1.065 . . . . 0.0 111.772 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -82.27 -15.05 54.4 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 m -144.82 165.35 28.36 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.769 2.028 . . . . 0.0 111.213 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -69.49 143.45 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.192 -0.942 . . . . 0.0 110.27 169.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 p -132.61 173.76 11.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.5 1.12 . . . . 0.0 112.494 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.8 p -137.85 169.98 16.85 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 111.819 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 pp -52.24 -32.06 35.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.376 1.07 . . . . 0.0 112.769 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.81 -19.58 61.97 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.547 0.739 . . . . 0.0 112.869 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -94.82 -38.47 10.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.392 1.077 . . . . 0.0 111.664 170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -60.97 -33.94 73.99 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.83 1.252 . . . . 0.0 112.907 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -59.77 -21.01 60.17 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -5.11 37.9 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.02 -1.05 . . . . 0.0 113.457 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -118.58 4.85 11.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.656 1.182 . . . . 0.0 114.077 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.4 m -73.54 159.95 32.39 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.978 -1.076 . . . . 0.0 113.746 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.6 t30 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 126.83 2.052 . . . . 0.0 112.41 174.337 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.335 0.112 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.34 155.32 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.004 1.322 . . . . 0.0 112.044 -169.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.99 70.83 0.83 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.244 1.818 . . . . 0.0 110.556 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -143.61 177.57 8.4 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.998 2.119 . . . . 0.0 110.093 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -70.13 141.37 52.69 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.749 -0.595 . . . . 0.0 110.717 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.0 mt -137.52 115.83 11.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.885 2.074 . . . . 0.0 108.726 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 94.1 m -117.54 149.36 40.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.661 1.184 . . . . 0.0 111.047 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 -116.01 6.24 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.933 0.778 . . . . 0.0 113.673 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 48.7 p -59.51 -35.04 73.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.438 1.095 . . . . 0.0 113.614 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -70.02 -38.31 75.87 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.488 -0.757 . . . . 0.0 111.334 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.9 -49.34 73.05 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 110.698 178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.19 -34.11 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.61 -44.74 85.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.719 0.69 . . . . 0.0 111.356 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.5 87.85 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.25 0.62 . . . . 0.0 112.409 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.63 -45.96 90.43 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.229 1.012 . . . . 0.0 110.852 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.27 -37.94 89.23 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.79 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 38.6 tp -70.35 -31.12 68.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 112.784 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 -40.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.632 -0.668 . . . . 0.0 111.193 174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.19 -28.57 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.494 0.588 . . . . 0.0 111.914 173.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 60.39 4.93 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.922 1.725 . . . . 0.0 112.927 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 65.08 8.57 4.85 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -22.65 57.13 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.055 -1.028 . . . . 0.0 113.53 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.45 175.35 48.65 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.062 1.315 . . . . 0.0 113.256 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.19 168.44 24.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.776 1.63 . . . . 0.0 112.714 -171.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -116.66 123.82 48.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.509 1.523 . . . . 0.0 109.996 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -91.01 119.06 30.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.311 1.053 . . . . 0.0 110.727 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.18 134.38 55.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.272 1.829 . . . . 0.0 110.512 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.8 pttp -151.43 169.85 8.74 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 126.155 1.782 . . . . 0.0 111.903 -172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.05 -25.54 44.0 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.026 2.484 . . . . 0.0 115.52 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.822 1.649 . . . . 0.0 114.341 -172.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 19' ' ' TYR . 10.3 tp -60.97 -35.4 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.011 0.924 . . . . 0.0 113.221 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -69.84 -39.81 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.276 -0.89 . . . . 0.0 111.117 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.5 -26.08 65.28 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.717 1.207 . . . . 0.0 112.016 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.6 tp60 -88.95 -44.3 10.53 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.743 1.217 . . . . 0.0 113.144 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -111.08 -31.57 7.07 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.4 t -82.06 -48.53 11.28 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.317 1.417 . . . . 0.0 111.783 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 t -91.45 -7.72 49.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -147.22 168.64 21.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.722 1.609 . . . . 0.0 111.829 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.8 mt -70.7 143.28 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.878 0.871 . . . . 0.0 110.188 170.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -131.8 179.92 5.78 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.732 1.213 . . . . 0.0 112.745 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 t -146.79 165.0 31.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 111.599 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.0 -35.07 45.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 112.395 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -64.54 -24.18 67.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.766 1.227 . . . . 0.0 113.252 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -92.54 -44.73 8.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.881 1.673 . . . . 0.0 110.287 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 mt -58.78 -36.41 74.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.403 1.481 . . . . 0.0 112.972 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.15 -20.97 44.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -75.15 -5.16 42.85 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.215 -0.928 . . . . 0.0 113.322 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 2' ' ' ILE . 41.7 m-85 -116.72 3.59 13.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.677 1.191 . . . . 0.0 113.855 -177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -73.67 162.7 28.9 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.216 -0.928 . . . . 0.0 113.087 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.102 1.361 . . . . 0.0 112.542 173.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.227 0.061 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.72 161.38 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.49 1.516 . . . . 0.0 111.875 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -115.74 98.83 6.9 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.161 1.385 . . . . 0.0 109.006 172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -154.36 167.02 31.38 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.931 1.693 . . . . 0.0 109.915 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.17 129.49 38.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 60.2 mt -130.87 113.24 13.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.783 1.633 . . . . 0.0 107.904 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.05 154.58 50.99 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.418 1.087 . . . . 0.0 111.407 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.39 -123.29 32.74 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.435 0.541 . . . . 0.0 112.706 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.2 p -59.7 -33.47 71.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -69.83 -38.54 76.58 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.53 -0.731 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.84 -49.56 74.42 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.049 1.34 . . . . 0.0 110.82 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.0 -35.68 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.33 -44.68 82.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.003 0.82 . . . . 0.0 111.149 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.03 -44.48 84.56 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.704 -0.622 . . . . 0.0 112.39 176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.6 -44.78 93.0 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.574 0.75 . . . . 0.0 110.999 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.87 -37.2 85.94 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.159 0.984 . . . . 0.0 112.705 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.58 -32.98 72.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.634 0.773 . . . . 0.0 112.595 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.25 -41.08 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.848 0.859 . . . . 0.0 110.801 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 65.3 m -71.86 -23.16 61.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 112.729 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.3 61.92 5.05 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.253 1.883 . . . . 0.0 113.321 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 62.39 7.53 2.37 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -72.25 -24.44 61.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.304 1.041 . . . . 0.0 113.041 175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.5 169.06 45.54 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.367 0.984 . . . . 0.0 112.716 -169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.24 168.43 23.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.004 1.722 . . . . 0.0 112.802 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -129.0 116.4 19.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.188 1.795 . . . . 0.0 110.046 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -84.58 31.41 0.53 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.104 1.361 . . . . 0.0 114.473 -171.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.281 82.2 p 52.0 39.02 25.38 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.384 1.873 . . . . 0.0 115.719 172.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.83 155.23 93.84 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.782 1.233 . . . . 0.0 112.123 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.69 -18.08 13.74 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.801 2.334 . . . . 0.0 114.427 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.134 1.374 . . . . 0.0 113.891 -177.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CD2' ' A' ' 19' ' ' TYR . 17.0 tt -63.54 -22.65 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -169.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -58.72 -35.11 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 120.593 -1.317 . . . . 0.0 111.264 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.18 -16.65 59.01 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.321 1.048 . . . . 0.0 112.822 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -86.73 -46.79 9.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.342 1.057 . . . . 0.0 112.832 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.04 -30.17 6.77 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 -169.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 t -83.27 -48.35 10.54 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.415 1.461 . . . . 0.0 111.123 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.5 p -89.67 -10.19 46.74 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.492 1.294 . . . . 0.0 114.492 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 t -145.79 170.62 16.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.824 1.65 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.69 141.29 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.546 1.138 . . . . 0.0 110.743 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 p -138.63 161.4 37.22 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.696 0.798 . . . . 0.0 112.459 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.8 m -143.63 173.99 11.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.525 1.93 . . . . 0.0 110.609 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.06 -34.14 42.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.209 1.404 . . . . 0.0 112.953 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -69.01 -19.74 64.13 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -101.46 -33.2 10.06 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.734 1.214 . . . . 0.0 111.987 171.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.63 -36.71 84.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.947 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.57 -17.01 53.2 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.06 -16.19 63.71 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.79 -1.194 . . . . 0.0 113.396 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CD2' HD12 ' A' ' 2' ' ' ILE . 36.5 m-85 -111.16 24.34 13.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.423 1.489 . . . . 0.0 113.181 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.8 m -128.6 155.45 44.92 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.697 1.599 . . . . 0.0 112.963 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.14 1.376 . . . . 0.0 113.29 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.239 0.066 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.64 169.91 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.065 1.346 . . . . 0.0 113.783 -169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.62 73.14 1.11 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.789 2.036 . . . . 0.0 107.898 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -143.23 166.29 25.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.602 1.561 . . . . 0.0 111.57 -169.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -72.88 141.52 47.92 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 167.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.5 mt -141.54 121.51 13.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.735 2.014 . . . . 0.0 108.222 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.48 152.04 50.12 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.501 -0.749 . . . . 0.0 112.192 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -120.87 24.6 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.461 0.553 . . . . 0.0 112.123 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.9 p -61.55 -33.1 73.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.1 0.96 . . . . 0.0 113.58 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -68.95 -38.45 79.46 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.424 0.69 . . . . 0.0 111.379 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.35 -49.01 75.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.255 1.022 . . . . 0.0 110.729 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.74 -35.65 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.37 -43.88 89.36 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.663 0.665 . . . . 0.0 110.813 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -43.63 77.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.161 0.585 . . . . 0.0 112.29 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 45.1 tp -60.04 -43.88 95.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.622 1.169 . . . . 0.0 111.469 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.31 -43.05 82.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.439 1.096 . . . . 0.0 111.918 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.23 -31.77 70.55 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.871 0.868 . . . . 0.0 112.559 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.12 -42.96 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.091 0.956 . . . . 0.0 110.453 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -81.32 -15.67 54.7 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.34 54.33 24.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.457 1.503 . . . . 0.0 114.483 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 64.29 15.45 9.44 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -68.95 -27.61 65.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.866 -1.146 . . . . 0.0 112.717 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.68 129.05 5.85 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.892 1.711 . . . . 0.0 112.1 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -136.7 161.63 35.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.047 1.739 . . . . 0.0 112.468 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -146.22 133.73 20.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 170.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -89.43 113.6 24.96 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.532 1.158 . . . . 0.0 111.605 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -83.03 54.78 2.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 112.605 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.53 151.92 96.95 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.211 1.404 . . . . 0.0 112.352 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.03 155.04 41.21 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.739 2.96 . . . . 0.0 114.128 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.197 1.799 . . . . 0.0 112.805 -178.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.296 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' CD2' ' A' ' 19' ' ' TYR . 20.5 tt -59.5 -22.65 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.92 -32.33 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.91 -1.119 . . . . 0.0 111.446 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.26 -20.67 62.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.516 1.526 . . . . 0.0 113.16 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -93.69 -50.26 5.47 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.627 1.571 . . . . 0.0 112.486 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.6 m -105.6 -30.21 9.65 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -168.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.0 t -81.91 -48.53 11.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.813 1.188 . . . . 0.0 111.241 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.6 t -89.86 -11.39 42.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.66 1.184 . . . . 0.0 114.061 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -144.62 176.04 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.36 1.464 . . . . 0.0 112.078 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.0 138.03 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.234 1.014 . . . . 0.0 111.306 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.76 147.46 40.92 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.772 1.629 . . . . 0.0 110.589 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -137.96 163.21 32.09 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.775 1.63 . . . . 0.0 109.516 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.2 tp -42.51 -44.52 4.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.497 1.919 . . . . 0.0 112.435 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -69.23 -23.65 63.9 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -91.77 -34.27 14.66 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.276 . . . . 0.0 111.151 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.19 -38.02 72.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.664 1.586 . . . . 0.0 112.581 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -62.04 -20.43 63.94 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.9 -1.125 . . . . 0.0 113.483 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -61.9 -20.03 63.32 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.176 0.99 . . . . 0.0 113.134 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 2' ' ' ILE . 78.1 m-85 -102.17 -5.99 23.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.783 1.233 . . . . 0.0 113.628 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.84 155.19 39.05 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.511 1.051 . . . . 0.0 112.054 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.955 1.302 . . . . 0.0 113.075 176.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.481 0.181 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.13 168.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 112.395 -174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -122.28 89.8 3.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.274 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -152.63 163.22 40.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.356 1.062 . . . . 0.0 111.889 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -68.72 139.09 55.36 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 167.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.6 mt -143.41 118.11 9.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.146 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 t -136.87 152.18 49.94 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.382 0.673 . . . . 0.0 112.102 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.34 -123.18 32.2 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.809 -0.557 . . . . 0.0 112.377 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -61.04 -32.41 72.03 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -68.01 -39.27 83.21 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.554 0.616 . . . . 0.0 111.184 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.66 -50.2 70.2 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.6 1.16 . . . . 0.0 110.718 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.57 -35.5 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.15 -44.48 79.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.861 0.755 . . . . 0.0 111.362 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -42.9 79.95 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.07 -44.02 90.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.519 0.728 . . . . 0.0 110.675 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.99 -38.38 90.96 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 111.862 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.8 tp -67.39 -31.05 71.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.171 0.896 . . . . 0.0 112.539 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.99 -40.84 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.625 1.17 . . . . 0.0 111.341 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -72.85 -23.83 60.8 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.374 -0.829 . . . . 0.0 110.974 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.56 -49.15 1.02 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 129.813 3.578 . . . . 0.0 114.269 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.99 -10.79 0.05 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.034 2.533 . . . . 0.0 113.919 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -68.42 -24.8 64.79 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.409 1.084 . . . . 0.0 113.2 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.49 169.71 18.02 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.478 1.037 . . . . 0.0 112.662 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.13 168.46 19.96 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -137.4 134.17 35.61 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.983 1.713 . . . . 0.0 110.242 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -89.56 1.19 56.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.566 1.946 . . . . 0.0 115.72 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 28.5 p 53.71 28.79 8.54 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 171.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.14 103.43 36.17 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 126.245 1.818 . . . . 0.0 109.368 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.4 150.83 47.19 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.014 2.476 . . . . 0.0 112.41 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.633 1.573 . . . . 0.0 111.167 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp -57.1 -37.92 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 117.945 0.873 . . . . 0.0 112.975 -170.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.21 -42.92 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 120.946 -1.096 . . . . 0.0 110.862 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -75.85 -14.71 60.29 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.344 1.058 . . . . 0.0 112.637 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -95.99 -42.48 8.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.414 1.086 . . . . 0.0 112.917 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.2 m -106.06 -30.89 9.0 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.93 -46.85 6.99 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.278 1.399 . . . . 0.0 111.741 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -82.87 -11.86 57.87 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -146.21 174.76 11.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.233 1.813 . . . . 0.0 111.36 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 79.9 mt -75.88 142.77 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.37 1.068 . . . . 0.0 110.251 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.6 p -134.96 174.01 11.08 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.397 1.079 . . . . 0.0 112.866 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -143.26 172.23 13.03 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.577 1.551 . . . . 0.0 111.147 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' H ' ' HB3' ' B' ' 1' ' ' PHE . 56.5 tp -41.37 -43.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.1 2.56 . . . . 0.0 112.475 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.25 -14.15 62.48 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -102.43 -40.48 6.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.977 1.311 . . . . 0.0 111.279 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.11 -39.06 77.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.745 1.218 . . . . 0.0 112.942 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -62.03 -17.98 59.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -76.77 -5.31 47.64 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.284 0.947 . . . . 0.0 113.394 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' A' ' 2' ' ' ILE . 42.9 m-85 -115.01 -0.43 13.38 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.7 m -68.21 156.98 36.47 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.2 t30 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 124.945 1.298 . . . . 0.0 113.227 -177.175 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.5 ' HB3' ' H ' ' A' ' 13' ' ' LEU . 88.5 t80 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.277 26.3 m 51.69 -46.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 130.624 3.57 . . . . 0.0 118.821 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 49.47 45.28 24.04 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.954 1.702 . . . . 0.0 112.669 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -144.79 159.77 42.33 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.835 1.654 . . . . 0.0 110.81 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -73.95 148.6 42.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.398 0.618 . . . . 0.0 109.473 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.2 mt -140.16 111.01 6.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.225 2.21 . . . . 0.0 108.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 92.9 m -118.59 149.38 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.762 1.225 . . . . 0.0 111.216 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.59 -115.95 5.96 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.209 0.909 . . . . 0.0 113.428 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -59.59 -34.59 72.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.926 0.891 . . . . 0.0 113.019 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.37 -38.53 74.77 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.099 0.56 . . . . 0.0 111.663 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.02 -47.78 81.58 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.581 1.153 . . . . 0.0 110.827 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -74.77 -37.11 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.51 -43.95 75.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.789 0.722 . . . . 0.0 111.776 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -42.28 92.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.458 0.703 . . . . 0.0 112.024 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.9 -43.26 88.7 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.037 0.535 . . . . 0.0 111.237 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -64.12 -36.4 83.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.033 -1.042 . . . . 0.0 112.752 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.51 -34.52 78.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.1 0.96 . . . . 0.0 112.279 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -75.34 -40.11 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.129 0.972 . . . . 0.0 111.648 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.06 -24.62 61.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.22 0.608 . . . . 0.0 111.948 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.65 61.71 4.82 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.597 1.57 . . . . 0.0 113.076 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 63.36 7.4 2.9 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.382 1.873 . . . . 0.0 115.516 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -77.54 -16.18 58.82 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 120.915 -1.116 . . . . 0.0 113.554 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 175.64 36.84 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 122.599 1.11 . . . . 0.0 113.204 -171.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -138.03 162.54 33.86 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.104 1.762 . . . . 0.0 112.103 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -141.62 -32.63 0.53 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.097 0.959 . . . . 0.0 113.226 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.33 24.2 p90 54.84 134.24 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 129.475 3.11 . . . . 0.0 115.65 -170.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 53.6 p 48.94 38.23 11.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.315 1.846 . . . . 0.0 114.122 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -63.01 134.81 95.94 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.383 1.873 . . . . 0.0 112.027 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 153.02 70.46 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.956 2.437 . . . . 0.0 112.637 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 37.8 p . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.125 1.77 . . . . 0.0 112.984 178.172 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD12 ' CD2' ' A' ' 19' ' ' TYR . 19.4 tt -62.48 -22.6 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -173.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.49 -32.55 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 120.716 -1.24 . . . . 0.0 110.946 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -79.9 7.35 9.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.076 1.751 . . . . 0.0 113.596 175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -124.92 -48.42 1.76 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.572 1.949 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.5 m -97.66 -31.31 12.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.1 t -86.45 -47.48 9.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.556 1.071 . . . . 0.0 111.692 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -80.77 -15.77 55.56 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -149.74 179.43 8.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.778 1.631 . . . . 0.0 111.609 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.35 139.76 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.783 0.833 . . . . 0.0 110.004 170.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.69 169.42 16.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.222 1.009 . . . . 0.0 112.231 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.7 p -144.19 173.69 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.374 1.47 . . . . 0.0 111.931 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.3 tp -43.93 -41.05 5.0 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.374 1.87 . . . . 0.0 111.808 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -74.42 -11.84 60.35 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -102.11 -41.4 6.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 111.128 169.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.15 -37.67 80.82 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.334 1.454 . . . . 0.0 113.094 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -60.01 -18.69 47.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -76.54 -5.6 48.29 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.625 ' CD2' HD12 ' A' ' 2' ' ' ILE . 53.9 m-85 -115.15 0.19 13.49 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.5 m -76.11 156.11 34.12 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.87 0.759 . . . . 0.0 112.701 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 113.644 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.39 159.02 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.182 0.993 . . . . 0.0 113.629 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.55 61.93 1.57 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.091 2.157 . . . . 0.0 110.038 178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 173.31 11.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.566 1.946 . . . . 0.0 111.038 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -71.75 142.44 49.75 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.657 -0.652 . . . . 0.0 109.621 168.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -137.97 114.2 10.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.472 1.909 . . . . 0.0 108.356 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.87 149.85 52.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.45 0.7 . . . . 0.0 112.053 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -122.56 30.32 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.347 0.499 . . . . 0.0 112.231 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 46.1 p -58.0 -34.64 70.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.428 1.091 . . . . 0.0 113.93 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -68.62 -37.93 80.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.317 0.647 . . . . 0.0 111.81 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.87 -51.71 60.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.697 0.799 . . . . 0.0 110.364 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.49 -35.6 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.87 -44.22 86.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.67 0.668 . . . . 0.0 111.497 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.58 76.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.477 0.711 . . . . 0.0 112.524 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.4 tp -64.46 -43.1 95.3 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.574 0.75 . . . . 0.0 110.635 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -65.71 -36.98 85.17 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.925 -1.109 . . . . 0.0 113.16 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.23 -36.18 83.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.837 0.855 . . . . 0.0 111.915 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.41 -38.11 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.204 1.001 . . . . 0.0 111.745 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 81.9 m -73.24 -22.1 60.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.568 0.747 . . . . 0.0 112.457 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.0 64.33 4.02 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.384 1.469 . . . . 0.0 113.301 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 67.86 2.46 3.1 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.943 1.697 . . . . 0.0 115.402 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -71.35 -40.39 70.71 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.587 -1.321 . . . . 0.0 112.942 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.34 171.35 42.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.335 0.969 . . . . 0.0 112.961 -168.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -139.91 -54.77 0.54 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.154 1.382 . . . . 0.0 113.923 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 48.63 30.09 2.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.767 1.627 . . . . 0.0 114.023 -172.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 26.0 p90 44.62 35.75 1.51 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.696 2.399 . . . . 0.0 115.052 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.279 57.7 p 51.11 31.6 6.77 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.735 2.014 . . . . 0.0 115.368 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -51.87 122.34 21.9 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.738 2.015 . . . . 0.0 112.145 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -70.18 144.54 52.08 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.295 2.664 . . . . 0.0 113.415 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.627 1.571 . . . . 0.0 110.81 176.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -61.99 -20.9 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.1 t -56.9 -33.33 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 120.339 -1.475 . . . . 0.0 110.919 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -75.32 -8.34 56.39 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.175 1.79 . . . . 0.0 113.625 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -104.13 -53.21 2.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.516 1.926 . . . . 0.0 111.3 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.1 m -107.73 -27.97 9.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -86.33 -46.36 10.36 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.555 1.071 . . . . 0.0 111.318 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -82.5 -13.24 57.02 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 t -151.36 171.66 17.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.634 1.574 . . . . 0.0 111.833 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -68.73 140.74 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.904 0.882 . . . . 0.0 110.027 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.97 165.54 25.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.06 0.944 . . . . 0.0 113.087 173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m -139.39 166.87 23.41 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.435 1.494 . . . . 0.0 110.94 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.26 -34.67 33.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.395 1.078 . . . . 0.0 112.967 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -65.53 -22.59 66.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.773 1.229 . . . . 0.0 113.277 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -91.9 -44.66 8.79 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.043 1.737 . . . . 0.0 110.47 172.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.89 -34.16 74.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.373 1.469 . . . . 0.0 113.29 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -60.37 -20.13 58.36 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -75.45 -4.51 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.353 0.978 . . . . 0.0 113.596 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -115.23 0.7 13.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.661 1.184 . . . . 0.0 114.07 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.82 154.94 35.84 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.714 -1.241 . . . . 0.0 114.259 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.481 1.912 . . . . 0.0 112.444 173.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.703 0.763 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.11 -38.66 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.686 1.594 . . . . 0.0 110.946 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -130.34 -176.04 3.83 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.706 2.002 . . . . 0.0 110.702 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 65.45 157.84 0.1 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.812 2.445 . . . . 0.0 115.563 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -77.28 144.9 37.81 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -132.4 114.54 14.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 107.743 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 t -134.88 152.12 51.48 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.556 0.742 . . . . 0.0 111.469 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.56 -122.77 31.17 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.401 0.524 . . . . 0.0 112.513 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 56.3 p -60.58 -33.32 72.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -68.75 -39.02 80.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.31 0.644 . . . . 0.0 111.43 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.63 -50.84 67.74 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.447 1.099 . . . . 0.0 110.903 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.95 -35.41 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.47 -45.98 81.59 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.786 0.721 . . . . 0.0 111.39 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.8 89.21 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.672 0.789 . . . . 0.0 112.136 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.87 -46.07 92.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 111.288 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -65.13 -37.83 88.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.895 0.878 . . . . 0.0 112.607 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 -40.38 94.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.956 0.902 . . . . 0.0 111.098 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -74.02 -35.89 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.262 0.625 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 77.0 m -70.99 -27.69 63.89 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 0.629 . . . . 0.0 111.97 171.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.19 65.21 2.86 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.843 1.687 . . . . 0.0 112.839 173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.79 3.38 2.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.935 1.694 . . . . 0.0 115.057 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.224 . . . . 0.0 114.112 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.76 178.85 47.09 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.178 0.894 . . . . 0.0 112.526 -169.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -152.47 170.22 20.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.2 1.4 . . . . 0.0 113.656 -171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -137.38 130.9 31.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.874 . . . . 0.0 109.64 168.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -86.16 2.86 45.21 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.296 43.1 p 58.44 39.75 24.82 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.121 1.768 . . . . 0.0 115.736 171.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -68.84 145.69 96.96 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 124.657 1.183 . . . . 0.0 110.814 169.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -64.17 -23.44 66.65 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.742 2.294 . . . . 0.0 115.44 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.14 1.776 . . . . 0.0 113.076 -176.763 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.1 tt -59.94 -21.97 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -175.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.54 -33.59 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.455 -1.403 . . . . 0.0 111.154 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -77.83 -8.33 57.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.399 1.48 . . . . 0.0 113.649 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -101.01 -49.54 4.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.007 1.723 . . . . 0.0 111.397 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.6 m -104.61 -28.5 11.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 50.1 t -95.75 -45.81 6.85 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.899 1.227 . . . . 0.0 112.203 -176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.9 p -81.26 -13.2 58.74 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -147.52 172.98 13.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.363 1.865 . . . . 0.0 110.815 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.5 139.16 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.454 -0.779 . . . . 0.0 110.207 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 p -127.03 164.84 20.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.606 1.162 . . . . 0.0 111.899 169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -137.54 169.91 16.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.399 1.48 . . . . 0.0 111.187 -172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -40.79 -46.05 2.6 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.066 2.147 . . . . 0.0 112.096 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -68.99 -16.45 63.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.502 1.121 . . . . 0.0 113.825 -175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -97.32 -41.53 8.21 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.638 1.175 . . . . 0.0 111.199 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.3 mt -60.37 -34.65 74.19 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.844 1.258 . . . . 0.0 112.82 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.04 -21.19 65.99 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.574 -1.329 . . . . 0.0 114.318 174.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -75.05 -5.4 43.88 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.529 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.0 m-85 -116.05 -2.04 12.34 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.3 t -84.15 146.34 27.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.424 1.489 . . . . 0.0 111.078 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.251 1.182 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.091 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.648 0.261 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.06 149.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.716 1.206 . . . . 0.0 113.339 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.75 38.35 0.68 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.727 1.611 . . . . 0.0 111.788 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -142.61 173.05 11.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.257 1.823 . . . . 0.0 111.288 -173.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -70.95 140.8 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.273 0.559 . . . . 0.0 110.274 169.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.3 mt -139.64 112.81 8.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.002 2.121 . . . . 0.0 109.146 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.3 m -116.45 142.44 46.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 111.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.32 -114.42 5.47 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.956 0.789 . . . . 0.0 113.425 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -58.9 -34.27 71.49 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.298 1.039 . . . . 0.0 113.519 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -70.07 -37.82 75.59 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.67 0.788 . . . . 0.0 111.398 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -65.4 -49.88 67.59 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.495 1.118 . . . . 0.0 110.774 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.95 -33.43 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.96 -44.34 85.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.59 0.632 . . . . 0.0 111.446 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.99 -43.8 86.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.108 0.563 . . . . 0.0 112.477 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 39.0 tp -66.0 -38.29 88.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.721 0.808 . . . . 0.0 111.671 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -68.29 -38.31 81.52 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.876 -1.14 . . . . 0.0 112.572 174.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 tp -65.24 -37.35 86.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.708 0.803 . . . . 0.0 112.179 173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.53 -38.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.946 0.899 . . . . 0.0 111.894 176.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 20.1 t -72.09 -19.86 61.74 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 112.466 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 51.78 50.21 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.099 1.809 . . . . 0.0 113.205 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 64.05 10.29 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.991 1.716 . . . . 0.0 115.104 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -75.62 -25.82 57.25 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.902 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 132.23 7.09 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.341 1.924 . . . . 0.0 113.512 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -112.6 164.57 13.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.322 1.849 . . . . 0.0 113.115 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -119.8 -17.46 8.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.808 1.643 . . . . 0.0 113.453 -173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.266 36.4 p90 49.58 19.72 0.42 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.229 2.211 . . . . 0.0 116.165 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.339 6.2 t 43.78 48.4 6.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.557 1.943 . . . . 0.0 112.975 -169.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 147.83 39.67 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.206 1.803 . . . . 0.0 114.004 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.42 152.2 30.0 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.246 2.63 . . . . 0.0 111.856 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.698 1.599 . . . . 0.0 110.87 175.221 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.402 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.523 HD13 ' CD2' ' A' ' 19' ' ' TYR . 9.3 tp -58.93 -37.09 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.897 0.879 . . . . 0.0 112.488 -173.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.22 -41.82 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.456 -0.778 . . . . 0.0 110.55 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -67.41 -31.24 71.31 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.515 -0.741 . . . . 0.0 111.769 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -88.78 -33.47 17.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.7 m -104.5 -37.11 7.29 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.53 -47.32 13.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.523 1.511 . . . . 0.0 111.91 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 t -104.16 0.11 29.18 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.764 1.226 . . . . 0.0 114.046 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.0 t -143.93 179.71 7.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.309 1.844 . . . . 0.0 111.424 172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 mt -86.67 141.51 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.03 . . . . 0.0 110.293 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.14 155.93 36.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.964 1.306 . . . . 0.0 111.825 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -124.45 171.23 10.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.67 1.588 . . . . 0.0 111.301 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.49 -31.54 35.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.964 0.906 . . . . 0.0 112.87 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -73.39 -28.78 62.2 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.264 0.625 . . . . 0.0 112.15 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -80.71 -44.73 18.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.499 0.72 . . . . 0.0 110.468 171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.1 mt -63.86 -42.2 97.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.672 1.589 . . . . 0.0 113.065 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.26 -22.01 66.79 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.843 -1.16 . . . . 0.0 113.904 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -73.96 -5.0 38.65 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' CD2' HD13 ' A' ' 2' ' ' ILE . 44.2 m-85 -107.8 -0.61 21.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.971 1.308 . . . . 0.0 113.68 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.45 143.13 53.65 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.788 -1.195 . . . . 0.0 110.494 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.199 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 119.546 -0.264 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.0 m -74.92 -50.5 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER 42.37 41.69 2.32 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.878 2.071 . . . . 0.0 115.439 178.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -151.48 163.07 39.82 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.072 1.749 . . . . 0.0 110.701 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -67.99 141.33 56.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -143.24 124.57 14.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 108.796 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.4 t -139.8 153.03 47.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.703 -0.623 . . . . 0.0 111.863 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.99 -122.62 30.54 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.71 0.671 . . . . 0.0 112.297 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 39.8 p -60.32 -32.33 71.13 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -69.16 -38.5 78.79 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.595 -0.691 . . . . 0.0 111.473 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 tt -64.59 -48.37 75.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.869 1.267 . . . . 0.0 111.062 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.85 -34.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 -43.4 86.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.132 0.878 . . . . 0.0 111.429 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.4 82.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.537 0.735 . . . . 0.0 112.621 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.86 -39.82 94.16 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.588 0.755 . . . . 0.0 111.118 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -69.31 -35.85 76.38 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.296 -0.877 . . . . 0.0 112.584 174.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -42.07 97.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.038 . . . . 0.0 111.493 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.3 t -77.02 -36.39 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 122.987 0.515 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -69.7 -17.42 63.47 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.022 -1.049 . . . . 0.0 112.066 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 54.0 51.22 51.38 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.076 1.322 . . . . 0.0 113.243 171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 66.8 9.89 7.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.354 1.862 . . . . 0.0 115.949 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -67.4 -25.4 65.93 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.688 -1.257 . . . . 0.0 112.612 169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.24 158.09 30.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.524 1.535 . . . . 0.0 113.335 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -138.5 163.7 31.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.688 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -139.34 128.78 24.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.882 1.673 . . . . 0.0 110.257 169.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -81.1 16.76 1.42 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.004 1.722 . . . . 0.0 114.47 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.288 1.8 t 57.87 -14.32 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 129.992 3.317 . . . . 0.0 118.509 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -78.76 146.96 69.98 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 124.656 1.183 . . . . 0.0 111.707 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.99 160.13 50.32 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.256 2.638 . . . . 0.0 113.089 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.91 1.684 . . . . 0.0 112.591 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.9 tp -58.06 -40.29 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.603 1.161 . . . . 0.0 112.947 -173.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.6 t -66.45 -38.29 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.756 0.822 . . . . 0.0 110.934 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.97 -8.43 56.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.626 1.571 . . . . 0.0 113.192 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -114.49 -37.18 4.38 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.851 1.26 . . . . 0.0 112.784 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.18 -37.83 8.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.9 t -83.93 -48.42 10.01 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.979 1.263 . . . . 0.0 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -87.18 -10.48 52.55 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 114.045 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -148.06 178.81 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.761 1.624 . . . . 0.0 111.529 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 mt -75.63 141.09 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.964 0.905 . . . . 0.0 110.512 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 p -136.09 167.82 20.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.695 0.798 . . . . 0.0 112.203 169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -146.91 177.4 9.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.375 1.87 . . . . 0.0 110.445 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.6 tp -40.14 -44.48 1.82 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.453 2.301 . . . . 0.0 111.914 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -71.48 -13.1 61.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -174.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -102.81 -40.53 6.52 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.323 1.449 . . . . 0.0 111.042 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.45 -36.95 79.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.913 1.285 . . . . 0.0 112.65 -177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -21.77 60.3 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -72.78 -7.03 48.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CD2' HD13 ' A' ' 2' ' ' ILE . 32.7 m-85 -119.72 4.58 11.04 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.813 1.245 . . . . 0.0 113.737 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -74.48 171.17 14.26 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.18 0.992 . . . . 0.0 112.183 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.975 2.11 . . . . 0.0 114.833 -173.316 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.8 t80 . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.4 153.69 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.35 -0.844 . . . . 0.0 112.658 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -130.48 91.55 3.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.189 1.395 . . . . 0.0 108.656 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.92 166.16 34.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.234 1.414 . . . . 0.0 110.817 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.67 139.71 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 166.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -138.95 117.44 12.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.597 1.959 . . . . 0.0 108.0 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -136.42 153.15 51.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.625 0.77 . . . . 0.0 111.756 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.45 -124.11 35.41 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.257 0.456 . . . . 0.0 112.286 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -59.02 -32.42 69.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.879 0.872 . . . . 0.0 113.278 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -69.65 -39.09 77.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.133 0.573 . . . . 0.0 111.836 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.66 -49.82 71.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.741 1.216 . . . . 0.0 110.694 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.39 -35.7 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.03 -44.97 83.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.172 0.896 . . . . 0.0 111.279 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.51 -42.78 91.68 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.421 0.689 . . . . 0.0 112.483 176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.9 tp -68.17 -37.34 80.88 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.575 -0.703 . . . . 0.0 111.796 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -67.32 -39.56 85.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.929 -1.107 . . . . 0.0 112.091 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.31 -38.42 90.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -74.56 -40.33 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.203 1.001 . . . . 0.0 111.417 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -71.28 -23.8 62.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.396 0.678 . . . . 0.0 112.722 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.72 52.79 27.43 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.475 1.512 . . . . 0.0 113.344 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 61.54 29.09 18.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.899 1.28 . . . . 0.0 114.35 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -100.17 -12.18 19.81 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 92.03 1.18 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.801 1.191 . . . . 0.0 113.422 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -72.68 169.65 16.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.094 2.157 . . . . 0.0 114.56 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -111.77 153.52 26.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.483 1.913 . . . . 0.0 109.818 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -137.05 134.59 36.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.286 1.041 . . . . 0.0 112.141 170.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.4 p -77.03 155.18 32.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.649 1.58 . . . . 0.0 112.332 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -64.55 133.54 95.73 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.506 1.122 . . . . 0.0 111.3 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -66.97 -26.38 43.74 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.939 2.426 . . . . 0.0 115.167 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.009 1.724 . . . . 0.0 113.364 -174.356 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 N-CA-C 112.679 -0.168 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.408 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.5 tp -61.06 -43.07 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.163 0.985 . . . . 0.0 113.172 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.39 -38.22 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.669 -1.269 . . . . 0.0 111.033 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.88 -12.99 61.18 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.964 2.505 . . . . 0.0 113.794 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -120.88 -38.19 2.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.371 1.068 . . . . 0.0 113.6 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 94.3 m -102.51 -28.95 11.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -95.97 -50.54 4.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.664 1.12 . . . . 0.0 111.971 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -80.76 -11.08 59.67 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -146.45 -174.4 4.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.58 1.952 . . . . 0.0 110.466 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.7 mt -96.48 140.07 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.773 1.229 . . . . 0.0 110.309 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -128.71 176.43 7.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.472 1.509 . . . . 0.0 111.826 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.8 m -133.49 166.22 23.05 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.906 1.682 . . . . 0.0 111.697 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -29.74 46.87 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.707 1.203 . . . . 0.0 113.625 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -70.61 -19.36 62.84 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.535 1.134 . . . . 0.0 113.532 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -96.24 -39.79 9.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.232 1.013 . . . . 0.0 111.372 169.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.0 -37.1 78.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.413 1.085 . . . . 0.0 112.76 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.36 -20.42 64.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.91 -8.59 56.66 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.356 0.98 . . . . 0.0 112.721 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 2' ' ' ILE . 22.4 m-85 -110.93 -0.19 16.88 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.473 1.509 . . . . 0.0 113.874 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 65.1 m -67.31 157.35 34.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 112.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.27 1.428 . . . . 0.0 113.152 -176.621 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.167 0.032 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.23 160.01 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 125.409 1.483 . . . . 0.0 112.608 -175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -122.0 87.74 2.81 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.513 1.525 . . . . 0.0 109.52 174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.01 173.93 11.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.842 2.057 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -72.28 135.99 46.14 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.57 0.7 . . . . 0.0 109.648 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -134.08 101.63 5.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.777 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -115.64 150.17 37.15 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.995 1.318 . . . . 0.0 111.336 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.38 -115.02 5.28 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.113 0.863 . . . . 0.0 113.709 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 55.4 p -60.81 -35.91 77.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -70.35 -36.64 74.33 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.459 -0.776 . . . . 0.0 111.621 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.81 -49.37 77.76 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.591 1.156 . . . . 0.0 111.047 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 -35.38 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.59 -44.5 86.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.792 0.724 . . . . 0.0 111.132 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -42.56 81.91 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.586 -0.696 . . . . 0.0 112.313 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.95 -42.46 99.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.638 0.775 . . . . 0.0 111.067 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -68.46 -34.46 75.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.317 -0.864 . . . . 0.0 112.813 175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.15 -35.62 80.09 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.995 0.918 . . . . 0.0 112.298 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.93 -39.69 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.638 0.775 . . . . 0.0 111.276 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 79.6 m -69.93 -19.17 63.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.049 -1.032 . . . . 0.0 112.006 172.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.72 52.1 50.67 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.805 1.184 . . . . 0.0 113.312 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 67.49 8.74 6.52 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.405 1.882 . . . . 0.0 116.051 -174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -68.78 -19.31 64.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.611 -1.306 . . . . 0.0 112.281 168.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.87 168.63 35.0 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.848 1.213 . . . . 0.0 112.509 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -135.51 164.08 28.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.457 1.103 . . . . 0.0 113.843 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.11 -35.82 0.55 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.043 1.737 . . . . 0.0 112.988 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.351 41.6 p90 47.8 -81.63 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.235 2.214 . . . . 0.0 114.635 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -136.94 0.66 2.42 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.59 1.556 . . . . 0.0 114.385 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -145.61 129.94 8.8 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.555 1.142 . . . . 0.0 112.737 -169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.34 -25.19 7.19 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.808 2.338 . . . . 0.0 113.407 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.517 1.927 . . . . 0.0 112.429 -177.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.6 tt -76.02 -23.03 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.61 -37.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 120.503 -1.373 . . . . 0.0 110.19 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -75.4 -4.04 37.15 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.397 1.479 . . . . 0.0 113.935 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -106.86 -46.82 3.86 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.612 1.565 . . . . 0.0 113.447 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.98 -28.16 7.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.042 1.337 . . . . 0.0 114.15 -170.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.9 t -83.13 -44.84 14.65 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.109 -0.994 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t -89.24 -9.74 49.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 t -152.64 171.34 18.32 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.334 1.453 . . . . 0.0 111.895 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.99 143.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.711 1.205 . . . . 0.0 109.611 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.4 p -138.23 163.7 31.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.336 1.054 . . . . 0.0 113.159 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -137.12 173.46 11.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.039 1.336 . . . . 0.0 112.713 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mp -44.91 -41.02 6.83 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.284 1.834 . . . . 0.0 112.355 171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -67.78 -14.47 62.98 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -106.86 -38.17 6.15 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.787 1.235 . . . . 0.0 111.835 170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.73 -38.16 84.17 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.319 1.048 . . . . 0.0 112.155 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.88 -17.71 57.54 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -77.2 -7.2 55.47 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -114.12 5.34 15.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.9 m -74.75 160.19 31.04 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.1 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.55 1.94 . . . . 0.0 112.448 174.789 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.7 160.89 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.24 1.016 . . . . 0.0 113.189 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -112.68 31.55 6.28 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.247 1.819 . . . . 0.0 110.855 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.75 159.2 39.14 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.437 1.895 . . . . 0.0 111.939 -175.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -73.34 149.12 42.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.318 0.647 . . . . 0.0 109.845 169.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.2 mt -132.53 117.57 18.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.587 1.555 . . . . 0.0 108.767 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.87 153.29 51.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.956 0.902 . . . . 0.0 111.734 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.92 -122.82 31.5 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.669 -0.644 . . . . 0.0 112.471 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.9 p -59.86 -33.43 71.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -69.45 -38.14 77.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.545 0.738 . . . . 0.0 111.21 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -65.18 -49.64 69.02 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.883 1.273 . . . . 0.0 110.911 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.41 -34.16 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.45 -44.99 81.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.706 0.684 . . . . 0.0 111.194 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -42.76 89.52 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.236 0.614 . . . . 0.0 112.513 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.81 -44.45 93.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.545 0.738 . . . . 0.0 111.194 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -64.29 -37.08 86.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.328 1.051 . . . . 0.0 112.86 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.47 -36.54 84.19 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.786 0.835 . . . . 0.0 112.202 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.74 -35.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 112.09 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 67.0 m -73.8 -17.48 61.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.328 0.651 . . . . 0.0 112.077 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.06 10.41 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.95 1.738 . . . . 0.0 113.434 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 65.98 7.04 4.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -76.05 -22.68 55.44 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.18 -0.95 . . . . 0.0 112.812 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 178.39 46.93 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.61 1.576 . . . . 0.0 113.154 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.83 168.27 24.2 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 0.0 112.905 -172.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -138.2 99.89 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.11 1.764 . . . . 0.0 109.137 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -7.0 53.33 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.315 7.6 t 56.17 -46.19 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 130.61 3.564 . . . . 0.0 117.803 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt 61.82 152.79 0.11 Allowed Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 130.015 3.326 . . . . 0.0 115.495 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.21 -19.17 20.21 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.954 2.436 . . . . 0.0 113.411 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.666 1.987 . . . . 0.0 112.222 -176.529 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -69.07 -35.75 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.637 -0.92 . . . . 0.0 113.244 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.9 t -71.39 -38.65 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.128 0.971 . . . . 0.0 110.794 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -63.38 -30.11 71.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.746 1.618 . . . . 0.0 112.48 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -88.31 -41.08 13.11 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.8 m -110.01 -31.22 7.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -87.33 -48.38 8.04 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.015 1.28 . . . . 0.0 111.758 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.6 t -89.55 -10.26 46.82 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.6 m -141.26 165.09 28.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.472 1.909 . . . . 0.0 111.555 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.16 142.58 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.665 0.786 . . . . 0.0 110.131 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.19 161.16 36.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.264 1.026 . . . . 0.0 112.464 169.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.3 p -136.18 171.33 14.64 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.564 1.546 . . . . 0.0 111.95 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 tp -44.18 -39.64 4.5 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.479 1.912 . . . . 0.0 111.838 168.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -77.83 -14.3 59.62 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -95.68 -44.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.843 1.257 . . . . 0.0 110.134 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -30.96 69.84 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.359 1.863 . . . . 0.0 113.891 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -66.0 -16.93 64.33 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -75.7 -7.75 55.12 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.785 -1.197 . . . . 0.0 113.453 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.62 -7.02 23.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.507 1.123 . . . . 0.0 113.852 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.63 149.51 49.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.874 0.761 . . . . 0.0 111.997 171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.337 1.055 . . . . 0.0 113.711 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 t80 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.66 161.91 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.405 1.082 . . . . 0.0 113.804 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 58.77 1.63 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.33 1.852 . . . . 0.0 110.144 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -136.7 162.34 33.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.694 1.597 . . . . 0.0 111.885 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -71.46 145.05 49.48 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 167.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -138.15 115.91 11.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.598 1.959 . . . . 0.0 108.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -136.0 152.43 50.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.576 0.751 . . . . 0.0 111.909 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.15 -122.76 31.26 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.514 0.578 . . . . 0.0 112.2 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -60.18 -32.39 71.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 113.377 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -69.71 -39.17 77.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.05 0.54 . . . . 0.0 111.693 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.03 -48.59 78.09 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.598 1.159 . . . . 0.0 110.8 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.49 -34.48 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -66.3 -44.42 83.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.347 0.976 . . . . 0.0 111.238 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.63 79.2 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.471 0.708 . . . . 0.0 112.811 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 tp -67.63 -36.16 80.26 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.597 -0.69 . . . . 0.0 111.379 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.65 -40.8 84.53 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.437 -1.414 . . . . 0.0 111.921 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.76 -40.72 97.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.625 1.17 . . . . 0.0 111.986 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.25 -40.17 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.355 0.662 . . . . 0.0 111.489 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 4.2 t -71.97 -15.69 62.07 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.92 -1.113 . . . . 0.0 111.308 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 56.94 46.14 91.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.512 1.053 . . . . 0.0 112.903 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 54.08 19.61 2.16 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -171.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -67.61 -26.21 66.14 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.377 -0.827 . . . . 0.0 111.964 169.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.09 131.99 6.0 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.692 2.092 . . . . 0.0 113.529 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -124.23 166.22 16.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.215 1.406 . . . . 0.0 114.278 -171.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -117.48 138.16 52.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.055 1.742 . . . . 0.0 110.43 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -99.02 22.12 10.74 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.246 1.419 . . . . 0.0 113.55 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 49.5 p 53.03 -114.92 0.9 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.26 1.824 . . . . 0.0 113.847 174.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.16 88.51 21.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.375 1.87 . . . . 0.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -71.44 -28.3 18.08 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.674 2.249 . . . . 0.0 116.336 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.251 1.141 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 121.237 0.354 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.54 HD12 ' CD2' ' A' ' 19' ' ' TYR . 13.1 tt -67.57 -23.23 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -169.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 -28.26 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.337 -1.477 . . . . 0.0 111.137 173.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -89.23 11.6 18.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.525 1.93 . . . . 0.0 112.765 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -123.21 -57.16 1.7 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.045 1.738 . . . . 0.0 112.209 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.1 m -102.55 -18.08 15.45 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -169.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.3 t -88.47 -36.57 16.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.294 0.952 . . . . 0.0 111.344 170.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 p -81.63 -18.69 43.78 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.771 1.629 . . . . 0.0 114.038 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.0 t -151.63 174.58 13.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 111.664 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 mt -72.34 143.12 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.964 0.905 . . . . 0.0 111.054 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -122.81 172.79 8.19 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.434 1.494 . . . . 0.0 112.129 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -146.05 169.63 18.28 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.142 1.377 . . . . 0.0 110.922 172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 tp -41.6 -45.47 3.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.171 2.188 . . . . 0.0 111.818 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -70.13 -14.96 62.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 113.684 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.83 -39.85 8.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.875 1.27 . . . . 0.0 110.979 169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.8 mt -60.22 -35.44 75.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.816 1.246 . . . . 0.0 112.991 -178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.76 -18.76 56.85 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -76.22 -6.97 53.75 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.03 0.832 . . . . 0.0 113.101 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.54 ' CD2' HD12 ' A' ' 2' ' ' ILE . 41.2 m-85 -117.17 10.01 13.7 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -173.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.2 m -78.29 159.48 28.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.784 0.834 . . . . 0.0 111.573 169.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 124.882 1.273 . . . . 0.0 113.068 177.064 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 p -70.33 135.2 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.175 -0.953 . . . . 0.0 111.952 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -124.97 82.64 2.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.356 1.063 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -144.5 174.67 10.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.585 2.354 . . . . 0.0 109.406 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -70.91 141.37 51.16 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.579 -0.701 . . . . 0.0 109.606 169.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.18 107.12 7.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.171 1.789 . . . . 0.0 109.077 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.4 m -114.77 142.25 46.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.855 1.262 . . . . 0.0 111.727 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.31 -114.7 5.34 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.993 0.806 . . . . 0.0 112.965 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.6 m -57.16 -36.13 70.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.78 1.232 . . . . 0.0 112.787 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -69.63 -38.24 77.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.198 0.599 . . . . 0.0 111.878 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 tt -65.13 -50.38 66.26 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.886 0.874 . . . . 0.0 110.398 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.28 -37.19 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 118.997 -0.525 . . . . 0.0 112.149 -175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.06 -46.12 78.9 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.827 0.74 . . . . 0.0 111.716 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.26 86.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.146 0.578 . . . . 0.0 112.403 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.8 tp -68.25 -41.64 80.84 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.307 0.643 . . . . 0.0 111.421 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -62.85 -40.01 96.16 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.048 -1.033 . . . . 0.0 112.323 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.41 -36.6 81.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 0.0 112.16 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -71.22 -40.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 118.663 0.665 . . . . 0.0 111.265 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 73.2 m -73.09 -30.9 64.0 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.37 56.54 19.35 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.808 1.194 . . . . 0.0 113.333 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.29 16.44 10.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.57 62.03 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.915 -1.115 . . . . 0.0 113.578 169.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.97 149.9 11.63 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.055 1.312 . . . . 0.0 111.839 -169.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -150.67 -43.21 0.12 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.616 1.166 . . . . 0.0 113.671 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.55 35.05 1.85 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.552 2.341 . . . . 0.0 115.476 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 30.9 p90 44.57 35.28 1.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.4 2.28 . . . . 0.0 115.961 173.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . 0.254 44.1 p 58.92 24.87 13.02 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -56.95 130.46 79.16 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.019 1.328 . . . . 0.0 110.82 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.46 -20.96 4.57 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.959 2.439 . . . . 0.0 114.485 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.508 1.523 . . . . 0.0 114.24 -174.569 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.466 0 CA-C-O 120.853 0.14 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 19' ' ' TYR . 16.3 tt -95.94 -23.69 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.24 -37.81 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.284 -1.51 . . . . 0.0 111.145 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.81 3.76 6.15 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.584 1.554 . . . . 0.0 114.245 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -107.59 -56.84 2.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.906 1.682 . . . . 0.0 111.019 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.3 m -97.43 -22.97 16.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -81.68 -41.73 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.627 1.103 . . . . 0.0 111.084 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -90.83 -13.32 34.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.004 1.322 . . . . 0.0 114.481 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -147.78 175.3 11.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.277 1.431 . . . . 0.0 111.996 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.62 143.21 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.404 1.082 . . . . 0.0 111.095 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.2 m -125.73 158.98 33.48 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.027 1.331 . . . . 0.0 111.466 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -146.87 172.92 12.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.687 1.595 . . . . 0.0 110.026 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 tp -39.8 -44.35 1.59 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.958 2.103 . . . . 0.0 112.083 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -72.46 -13.03 61.34 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -101.57 -42.76 6.11 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.951 1.301 . . . . 0.0 110.467 169.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -59.01 -33.79 71.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.258 1.423 . . . . 0.0 112.609 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.25 -18.26 57.49 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.55 -3.2 45.82 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 2' ' ' ILE . 46.4 m-85 -120.69 3.34 10.65 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -71.52 162.41 29.48 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.4 t30 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.647 1.979 . . . . 0.0 112.334 176.174 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 28.5 t80 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.16 150.41 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.296 1.039 . . . . 0.0 112.863 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.12 68.84 1.4 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.295 1.438 . . . . 0.0 110.716 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -139.21 172.8 12.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.066 1.747 . . . . 0.0 111.473 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -68.95 144.18 54.22 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 169.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 72.1 mt -138.46 113.4 9.19 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.01 1.724 . . . . 0.0 108.129 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -133.32 150.06 51.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 111.761 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.1 -123.28 32.59 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.426 0.536 . . . . 0.0 112.049 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -59.24 -34.18 71.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.891 0.876 . . . . 0.0 112.972 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -68.99 -38.84 79.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.893 0.477 . . . . 0.0 111.62 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.71 -53.43 54.6 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.913 0.885 . . . . 0.0 110.07 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.89 -35.85 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -66.05 -44.64 83.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.57 0.623 . . . . 0.0 111.62 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.1 -43.82 77.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 0.0 112.254 177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.41 -45.31 93.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.935 0.894 . . . . 0.0 110.938 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -65.63 -36.12 82.78 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.987 -1.07 . . . . 0.0 113.119 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.35 -38.4 87.53 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.929 0.891 . . . . 0.0 111.471 172.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 20.7 t -73.51 -38.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.764 0.826 . . . . 0.0 111.716 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.71 -16.8 61.67 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.682 0.793 . . . . 0.0 112.266 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.0 56.66 23.99 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.901 1.715 . . . . 0.0 113.326 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 67.0 8.44 6.13 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.64 -23.4 61.68 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.782 -1.199 . . . . 0.0 112.213 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.25 176.84 50.69 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 125.354 1.454 . . . . 0.0 112.496 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.52 163.33 33.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.124 1.37 . . . . 0.0 112.511 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -140.73 -26.32 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . 0.35 52.9 p90 46.83 -97.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.048 1.739 . . . . 0.0 113.828 -169.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 158.29 43.81 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.412 1.885 . . . . 0.0 111.321 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.19 150.99 94.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.018 0.927 . . . . 0.0 112.289 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -59.7 152.95 59.26 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.55 2.833 . . . . 0.0 113.735 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.761 1.624 . . . . 0.0 113.04 176.619 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tp -56.14 -40.1 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.703 1.601 . . . . 0.0 113.235 -174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.6 t -67.26 -35.41 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.864 0.866 . . . . 0.0 110.974 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.11 1.64 17.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.514 1.926 . . . . 0.0 113.168 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -122.46 -47.65 2.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.341 1.456 . . . . 0.0 112.079 173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.0 m -91.37 -36.96 13.52 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.8 t -83.83 -48.77 9.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.605 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -81.46 -16.81 50.84 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -148.75 -174.79 4.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.75 1.62 . . . . 0.0 111.64 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.08 139.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.118 0.967 . . . . 0.0 109.573 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.68 168.31 15.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.456 1.102 . . . . 0.0 112.119 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -143.03 171.87 13.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.825 1.25 . . . . 0.0 111.614 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -40.98 -43.67 2.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.698 2.399 . . . . 0.0 112.022 169.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -70.99 -14.25 62.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -102.78 -39.82 6.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.586 1.154 . . . . 0.0 111.175 169.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.32 -39.46 83.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.843 1.257 . . . . 0.0 112.955 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.04 -19.46 62.91 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -75.58 -7.44 54.23 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.076 0.853 . . . . 0.0 113.21 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 2' ' ' ILE . 34.2 m-85 -113.98 0.91 14.52 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.577 1.151 . . . . 0.0 113.787 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.5 m -72.53 158.78 35.04 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.561 1.944 . . . . 0.0 112.333 175.002 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.33 -24.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 53.83 51.4 14.95 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.577 1.551 . . . . 0.0 112.386 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -149.91 162.48 40.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.549 1.94 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -69.46 147.91 50.27 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -142.9 115.79 8.77 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.547 1.939 . . . . 0.0 108.485 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -137.29 154.08 50.17 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.619 0.768 . . . . 0.0 111.854 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.05 -124.95 36.79 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.293 0.473 . . . . 0.0 112.162 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -59.78 -32.27 70.46 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -69.37 -38.82 78.22 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.714 -0.616 . . . . 0.0 111.689 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.44 -48.8 76.27 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.803 1.241 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -73.82 -36.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.91 -45.37 82.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.586 0.63 . . . . 0.0 111.046 177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.68 -41.21 84.05 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.621 -0.674 . . . . 0.0 112.465 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 tp -65.24 -44.36 88.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.295 0.638 . . . . 0.0 110.946 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -64.35 -35.61 81.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.001 -1.062 . . . . 0.0 112.879 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -67.13 -35.77 80.45 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.078 0.951 . . . . 0.0 112.253 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 t -74.45 -39.67 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.714 0.806 . . . . 0.0 111.31 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 62.9 m -73.47 -18.62 61.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.703 0.801 . . . . 0.0 112.668 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 60.46 61.11 7.44 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.97 1.748 . . . . 0.0 113.333 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 65.1 7.42 4.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.264 1.826 . . . . 0.0 115.458 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -76.23 -20.45 57.43 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.016 -1.053 . . . . 0.0 112.994 173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.57 175.8 51.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.769 1.176 . . . . 0.0 113.414 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -147.01 168.23 22.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.969 1.708 . . . . 0.0 112.635 -174.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -125.11 164.65 19.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.307 1.843 . . . . 0.0 110.305 170.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -142.87 134.2 26.13 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.949 0.88 . . . . 0.0 112.346 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -117.21 144.61 44.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.186 1.794 . . . . 0.0 110.37 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -154.33 138.79 11.39 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 125.539 1.536 . . . . 0.0 110.052 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.56 117.11 4.2 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.3 2.0 . . . . 0.0 110.206 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.754 1.621 . . . . 0.0 111.479 -170.519 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.452 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.8 tt -72.76 -24.7 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.9 t -58.7 -37.37 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.128 -1.607 . . . . 0.0 110.626 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -77.93 -5.65 51.8 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.809 1.644 . . . . 0.0 113.676 173.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -100.35 -44.34 5.95 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.645 1.578 . . . . 0.0 112.823 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.78 -22.42 8.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.59 -45.44 9.87 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.957 1.253 . . . . 0.0 111.067 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -84.81 -13.44 51.09 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.1 t -147.83 -179.35 6.83 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.295 1.838 . . . . 0.0 111.033 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.73 142.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.995 -1.066 . . . . 0.0 110.999 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -124.6 170.49 10.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.18 0.992 . . . . 0.0 112.23 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -144.76 168.23 20.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.714 1.605 . . . . 0.0 110.864 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 tp -41.55 -43.11 2.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.165 2.186 . . . . 0.0 112.395 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -70.42 -27.08 64.0 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -82.49 -45.8 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 109.836 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.8 mt -57.83 -45.14 86.6 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.202 1.801 . . . . 0.0 112.646 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.98 -22.22 66.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.728 -1.232 . . . . 0.0 113.998 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -79.07 -0.88 33.23 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -105.7 16.18 25.72 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.804 1.242 . . . . 0.0 113.491 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 76.6 m -118.69 164.02 15.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.82 1.248 . . . . 0.0 113.627 -175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.658 1.983 . . . . 0.0 114.936 -169.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 26.9 m -89.69 156.75 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.335 1.054 . . . . 0.0 113.161 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -127.38 72.99 1.4 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.67 1.988 . . . . 0.0 106.978 172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.35 175.21 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.604 1.961 . . . . 0.0 111.313 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -76.7 142.12 40.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.242 0.617 . . . . 0.0 109.833 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 42.2 mt -141.75 125.57 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.741 2.016 . . . . 0.0 108.554 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.28 148.12 44.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.976 1.311 . . . . 0.0 111.419 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.67 -115.12 4.54 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.216 0.912 . . . . 0.0 113.87 170.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 45.8 p -59.41 -34.53 72.58 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.81 -39.09 76.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.438 0.695 . . . . 0.0 111.615 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 tt -65.81 -48.15 72.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.73 1.212 . . . . 0.0 111.291 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.16 -37.23 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.237 0.471 . . . . 0.0 112.094 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.6 -45.94 81.25 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.374 0.534 . . . . 0.0 111.293 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.79 93.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.01 -41.37 86.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.226 1.011 . . . . 0.0 111.6 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -66.5 -40.92 89.51 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.646 0.779 . . . . 0.0 112.03 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.1 -39.38 93.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.39 1.076 . . . . 0.0 111.811 176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.0 t -66.91 -43.17 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.404 0.681 . . . . 0.0 110.483 175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 89.0 m -83.92 -15.14 49.05 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 51.67 53.63 28.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.891 1.234 . . . . 0.0 114.325 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 66.44 14.31 9.65 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -67.28 -20.33 65.62 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.552 -1.342 . . . . 0.0 112.821 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.18 133.35 6.9 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.204 1.859 . . . . 0.0 112.095 -176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -136.15 -52.7 0.73 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.716 1.206 . . . . 0.0 114.049 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 1.2 t80 50.14 28.07 2.87 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.317 1.847 . . . . 0.0 115.013 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 41.5 p90 43.72 32.14 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.832 2.453 . . . . 0.0 116.379 171.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p 58.61 7.74 0.78 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? 32.86 60.63 1.51 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 128.427 2.691 . . . . 0.0 115.99 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.55 120.89 8.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.516 2.144 . . . . 0.0 110.847 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.175 1.79 . . . . 0.0 112.415 -174.533 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 CA-C-O 120.441 -0.089 . . . . 0.0 112.959 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 19' ' ' TYR . 7.1 tp -55.13 -40.2 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.366 1.466 . . . . 0.0 112.705 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.11 -37.28 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.178 0.991 . . . . 0.0 110.991 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.03 4.12 15.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.007 1.723 . . . . 0.0 113.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -123.83 -44.53 2.07 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.215 1.406 . . . . 0.0 111.842 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.2 -39.7 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -81.88 -48.59 11.35 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.579 1.081 . . . . 0.0 111.019 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.6 p -82.21 -16.19 50.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -149.88 -175.25 4.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.305 1.442 . . . . 0.0 111.733 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.2 mt -79.18 138.89 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.196 0.998 . . . . 0.0 109.84 170.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.7 p -131.68 160.17 36.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.988 0.915 . . . . 0.0 112.408 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -133.09 172.48 12.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.265 1.426 . . . . 0.0 111.787 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' HD12 ' A' ' 13' ' ' LEU . 6.6 mp -47.46 -38.72 14.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.74 2.016 . . . . 0.0 111.418 173.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -68.35 -18.31 64.46 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.603 1.161 . . . . 0.0 113.901 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 -98.81 -39.95 8.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.531 1.132 . . . . 0.0 111.186 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.9 mt -56.28 -39.92 73.43 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.841 1.256 . . . . 0.0 112.585 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.28 -15.46 47.7 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -77.52 -7.16 55.84 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.86 -1.15 . . . . 0.0 113.455 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 2' ' ' ILE . 40.1 m-85 -115.99 6.51 14.14 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.5 m -70.04 151.41 45.56 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.364 -0.835 . . . . 0.0 111.759 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.506 1.523 . . . . 0.0 112.651 -171.774 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . 0.326 26.7 m 45.91 45.18 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 126.483 1.913 . . . . 0.0 114.852 -172.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 64.53 55.22 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.658 1.983 . . . . 0.0 114.172 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.27 160.26 40.24 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.828 1.651 . . . . 0.0 112.694 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -78.74 144.84 34.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.808 0.843 . . . . 0.0 109.037 167.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -144.78 126.12 14.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.559 1.544 . . . . 0.0 109.695 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.2 155.1 48.05 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.707 -0.621 . . . . 0.0 111.921 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 59.36 -124.13 35.53 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.579 0.609 . . . . 0.0 112.469 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.87 -31.96 69.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.353 1.061 . . . . 0.0 113.153 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -70.89 -38.33 73.03 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.328 0.651 . . . . 0.0 111.682 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.92 -46.86 76.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.046 1.339 . . . . 0.0 110.748 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.68 -36.22 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.62 -45.35 83.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.694 0.679 . . . . 0.0 111.416 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.6 -41.37 88.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.332 0.653 . . . . 0.0 112.684 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.67 -41.37 88.24 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.438 -0.788 . . . . 0.0 111.511 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -65.13 -37.9 88.91 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.009 0.924 . . . . 0.0 112.428 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -41.27 96.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.836 1.254 . . . . 0.0 111.815 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 50.5 t -77.18 -34.49 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.213 0.605 . . . . 0.0 111.952 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.96 -27.41 62.76 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.547 0.612 . . . . 0.0 112.279 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.68 62.52 3.8 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.422 1.487 . . . . 0.0 113.12 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.73 6.75 2.81 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.036 1.734 . . . . 0.0 115.493 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -22.04 62.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.297 1.439 . . . . 0.0 113.722 173.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.11 166.44 36.06 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 122.203 0.891 . . . . 0.0 113.037 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.15 170.99 16.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.403 1.481 . . . . 0.0 113.252 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -111.69 147.52 35.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.607 1.563 . . . . 0.0 110.523 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -128.4 120.72 27.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 111.233 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -83.94 60.17 5.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.034 1.334 . . . . 0.0 112.456 -171.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 77.9 tttt 51.16 69.09 2.76 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 127.452 2.301 . . . . 0.0 114.644 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.29 -21.66 41.13 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.035 2.49 . . . . 0.0 113.557 172.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.544 1.938 . . . . 0.0 111.193 177.344 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.653 HD12 ' CD2' ' A' ' 19' ' ' TYR . 15.2 tt -62.85 -22.2 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -171.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.59 -30.79 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 120.286 -1.509 . . . . 0.0 111.312 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -80.9 6.02 14.43 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.08 1.752 . . . . 0.0 113.208 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -126.51 -44.78 1.68 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.126 1.77 . . . . 0.0 112.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -107.59 -24.2 11.85 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.5 t -96.32 -51.0 4.55 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.225 0.92 . . . . 0.0 112.286 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -70.98 -23.4 62.2 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.303 -0.873 . . . . 0.0 113.222 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -140.39 163.37 32.98 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 127.449 2.3 . . . . 0.0 110.228 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.6 mt -68.51 140.42 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.613 -0.679 . . . . 0.0 110.671 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 p -126.87 172.56 10.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 111.993 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 t -131.91 167.32 19.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.218 1.407 . . . . 0.0 112.329 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 pp -51.57 -31.08 23.16 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.782 1.633 . . . . 0.0 112.882 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -72.23 -19.67 61.68 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -93.45 -44.19 8.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.853 1.261 . . . . 0.0 110.431 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.2 mt -55.57 -37.18 67.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.295 1.438 . . . . 0.0 113.299 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -60.35 -17.91 46.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -75.47 -5.96 47.71 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.382 0.992 . . . . 0.0 113.123 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.653 ' CD2' HD12 ' A' ' 2' ' ' ILE . 32.2 m-85 -113.98 6.27 16.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.741 1.217 . . . . 0.0 113.759 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.8 m -73.88 157.85 35.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.7 t30 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.842 2.057 . . . . 0.0 112.62 174.785 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 119.969 -0.063 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.7 m -137.0 146.29 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.309 1.444 . . . . 0.0 111.399 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -92.31 133.28 35.99 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.335 1.054 . . . . 0.0 110.38 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -162.49 166.34 25.0 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.971 1.308 . . . . 0.0 111.169 -169.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -77.79 80.22 4.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.554 1.168 . . . . 0.0 108.005 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.2 mt -75.96 96.71 3.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.48 1.912 . . . . 0.0 109.745 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 81.6 m -107.44 141.29 39.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.264 1.426 . . . . 0.0 111.898 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.28 -113.35 3.65 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.987 0.803 . . . . 0.0 113.757 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -59.2 -34.56 72.31 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.275 1.03 . . . . 0.0 112.885 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.74 -38.89 80.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.345 0.521 . . . . 0.0 111.014 175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.17 -50.2 71.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.87 0.868 . . . . 0.0 110.868 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -71.09 -35.99 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -65.56 -45.08 84.71 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.721 0.691 . . . . 0.0 111.325 176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.09 -42.02 73.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.526 0.731 . . . . 0.0 112.596 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 42.5 tp -64.66 -41.24 96.25 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.772 -0.58 . . . . 0.0 110.656 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -66.54 -37.48 85.09 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.857 1.208 . . . . 0.0 112.765 174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 64.8 tp -64.19 -36.91 85.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.737 0.815 . . . . 0.0 112.157 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.42 -35.82 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.14 0.976 . . . . 0.0 111.649 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 82.4 m -71.63 -18.22 62.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 111.886 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 55.47 54.97 30.97 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.166 1.365 . . . . 0.0 113.352 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 66.66 7.44 5.16 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -68.29 -23.67 64.78 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.646 -1.284 . . . . 0.0 112.783 169.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.29 168.68 45.08 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.213 1.387 . . . . 0.0 112.579 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.83 -78.57 0.45 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 49.82 71.86 0.36 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.56 1.544 . . . . 0.0 111.484 -169.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.16 -41.68 68.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -168.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 80.4 p -146.89 167.35 24.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.552 1.541 . . . . 0.0 111.302 176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -139.59 152.24 68.23 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.137 1.775 . . . . 0.0 111.919 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.01 -22.55 11.33 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.025 2.483 . . . . 0.0 113.381 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.863 1.665 . . . . 0.0 112.243 -176.564 . . . . . . . . 0 0 . 1 stop_ save_